Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Researchers.
- Curriculum.
- Publications.
- Projects.
- Presentations.
- Advised theses.
Institutions.
Projects.
Publications.
Partners.
Sponsors.
Equipment.
Knowhow.
Fields of Research.

Brcic Luka |

Presentations at scientific and public conferences

Fukuoka, J; Uegami, W; Cooper, W; Brcic, L; Zaizen, Y; Wright, J; Pena, AT; Ishijima, S; Almutrafi, A; Beasley, MB; Cavazza, A; Kern, I; Wan, LF; Losmanova, T; Othman, N; Fabro, A; Yoshimura, M; Hebisawa, A; Okudela, K; Achcar, RD; Churg, A; Attanoos, R The CRYOSOLUTION Study: Standardizing Cryobiopsy Diagnosis for Interstitial Lung Disease by 20 Pathologists from 15 Countries
LAB INVEST. 2025; 105(3): Doi: 10.1016/j.labinv.2024.103926
Web of Science FullText FullText_MUG

Brcic, L Update on histology and molecular pathology in PM.
4TH THORACIC CANCERS ACADEMY; JAN 19-20, 2024; Zagreb, CROATIA. 2024. [Oral Communication]

Brcic, L Role of pathology in ILD- BAL and biopsy.
CTD-ILD preceptorship 2024; OCT 22-23, 2024; Graz, AUSTRIA. 2024. [Oral Communication]

Brcic, L Hot Topics in der Molekularpathologie. Zu viel oder zu wenig Liquid?
Interaktives Forum (IAF) Lungenkarzinom 2024; MAR 8, 2024; Vienna, AUSTRIA. 2024. [Oral Communication]

Brcic, L Update zielgerichtete Therapien beim NSCLC – Fokus KRAS Mutation und seltene Treiber. Diskutant.
OeGHO OnCoLine Webinar ; DEZ 03, 2024; Vienna, AUSTRIA. 2024.

Brcic, L Clinical Reports - Ask the Pathologist.
1. Lung Cancer DISCourse; OCT 18-19, 2024; Salzburg, AUSTRIA. 2024. [Oral Communication]

Brcic, L What to do with eosinophils in lung?
7th Pannonia Congress of Pathology; MAR 7-9, 2024; Vienna, AUSTRIA. 2024. [Oral Communication]

Brcic, L Molekularpathologische Diagnostik des NSCLC 2024.
Oncology Talks; JUN 26, 2024; Graz, AUSTRIA. 2024. [Oral Communication]

Brcic, L Mesothelioma-diagnostic criteria and classification-WHO 2021.
Academy of Molecular Pathology and Personalized Medicine “Lung Cancer”; APRIL 4-6, 2024; Sofia, BULGARIA. 2024. [Oral Communication]

Brcic, L Precision diagnostics of Lung Cancer, with panel discussion.
Academy of Molecular Pathology and Personalized Medicine “Lung Cancer”; APRIL 4-6, 2024; Sofia, BULGARIA. 2024. [Oral Communication]

Brcic, L Lung pathology: from beginner to expert: Pleural biopsy.
36th European Congress of Pathology ; SEP 7-11, 2024; Florence, ITALY. 2024. [Oral Communication]

Brcic, L Broad Molecular Reflex Testing in Non-Small Cell Lung Cancer to Squamous Cell Carcinoma Subtypes Regardless of Stage.
Visit to Department of Pathology at the Catholic University of Korea Uijeongbu St. Mary’s Hospital; NOV 12, 2024; Seoul, KOREA. 2024. [Oral Communication]

Brcic, L The role of MPR diagnostics in early-stage NSCLC.
2. NITOG-Symposium 2024: Neoadjuvant/perioperative treatment options in early-stage NSCLC. ZOOM Webinar; MAY 15, 2024; Innsbruck, AUSTRIA. 2024. [Onlinepräsentation]

Brcic, L The role of pathologist and best practice sharing.
Clinical pathway of early (neoadjuvant) NSCLC treatment in UMC Maribor; OCT 1, 2024; Maribor, SLOVENIA. 2024. [Oral Communication]

Brcic, L Diagnostic challenges in multifocal lung cancer.
Multifocal Lung Cancer - Round Table Discussion; OCT 14, 2024; Vienna, AUSTRIA. 2024. [Onlinepräsentation]

Brcic, L Keynote Presentation: Common Forms of Lung Cancer.
Mayo Clinic Thoracic Pathology Workshop 2024.; SEP13-14, 2024; 2024. [Keynote lecture]

Brcic, L The mediastinal case that kept me up all night.
36th European Congress of Pathology ; SEP; Florence, ITALY. 2024. [Oral Communication]

Brcic, L Metastatic tumors of the lung. Diagnostic principles. Role of IHC.
Academy of Molecular Pathology and Personalized Medicine “Lung Cancer”; APRIL 4-6, 2024; Sofia, BULGARIA. 2024. [Oral Communication]

Brcic, L Presidential Session: Artificial intelligence in der Onkologie-Podiumsdiskussion.
OeGHO- & AHOP-Frühjahrstagung 2024; APRIL 4-6, 2024; Vienna, AUSTRIA. 2024. [Oral Communication]

Brcic, L Molecular diagnostics in mesothelioma.
Molecular Diagnostics Training School 2024; FEB 26-28, 2024; Vienna, AUSTRIA. 2024. [Oral Communication]

Brcic, L; Forgo, N; Goebel, G; Gruber, F; Haslacher, H; Henrich, M; Henzinger, H; Kaltenbrunner, S; Kral, S; Mucher, P; Nep, P; Perz, V; Propadalo, E; Shekhovtsov, V; Valjan, M; Walter, I; Wieser, M; Stumptner, C Austrian Biobanking and BioMolecular resources Research Infrastructure - importatn partner for research on biological samples.
KALC-IC 2024; NOV 7-8, 2024; Seoul, KOREA. 2024. [Poster]

Brcic, L; MathiaN, É; Drouet, Y; Sexton-Oates, A; Papotti, M G; Pelosi, G; Vignaud, J-M; Mansuet-Lupo, A; Chen, L; Alcala, N; Fernandez-Cuesta, L; Lantuejoul, S; Foll, M Can AI Based on Morphology Provide Clinically More Meaningful Classification of Lung Neuroendocrine Tumours- lungNENomics Project Results.
KALC-IC 2024; NOV 7-8, 2024; Seoul, KOREA. 2024. [Poster]

Brcic, L; Pokieser, W Cytology, histology and molecular analyses in mesothelioma.
45th European Congress of Cytology; JUN 23-26, 2024; Leipzig, GERMANY. 2024. [Oral Communication]

Filipello, F; Blaauwgeers, JLG; Lissenberg-Witte, B; Minami, Y; Le Quesne, J; Papotti, M; Pelosi, G; Sansano, I; Berezowska, S; Ryska, A; Brcic, L; Motoi, N; Nakatani, Y; Kuempers, C; Rossi, G; Ambrosi, F; Matsubara, D; Ishikawa, Y; Weynand, B; Pezzuto, F; Kern, I; Nicholson, S; Mutka, A; Dacic, S; Beasley, MB; Arrigoni, G; Timens, W; Brinkhuis, M; Britstra, R; Bulkmans, N; Vreuls, W; Flieder, D; Jones, K; von der Thüsen, J; Perner, S; Moore, D; Hager, H; Leonte, D; Schonau, A; Kluck, K; Ourailidis, I; Ball, M; Budczies, J; Kazdal, D; Dale, VG; Stenzinger, A; Thunnissen, E Invasion Measurement and Adenocarcinoma In-Situ in Small Pulmonary Adenocarcinoma. A Reproducibility Study According to the WHO and a Modified Classification, Supported by Molecular Profiling
LAB INVEST. 2024; 104(3): S1909-S1911. [Poster]
Web of Science

Flick, H; Brcic, L; Talakic, E; Moazedi-Fürst, F; Kneidinger, N ILD-Board
Simulation ILD-Board; SEP 24, 2024; Graz, AUSTRIA. 2024. [Onlinepräsentation]

Flick, H; Moazedi- Fürst, F; Talakic, E; Brcic, L Patientenfall 1 und 2 (fiktiv).
ILD Board aus Graz: live, realitätsnah und zusammen mitdiskutieren; SEP 24, 2024; Graz, AUSTRIA. 2024. [Onlinepräsentation]

Göbel, G; Brcic, L Welcome Address- BBMRI Austria.
Europe Biobank Week Congress; MAY 14-17, 2024; Vienna, AUSTRIA. 2024. [Oral Communication]

John, N; Terbuch, A; Konjic, S; Absenger, G; Jost, PJ; Lindenmann, J; Fediuk, M; Sassmann, T; Wurm, R; Zacharias, M; Posch, F; Hochmaier, MJ; Fabikan, H; Weinlinger, C; Illini, O; Horvath, L; Gamerith, G; Pircher, A; Brcic, L Prognostic impact of targetable driver alterations in resected early-stage lung cancer
WIEN KLIN WOCHENSCHR. 2024; 136(S13):S531-S531.-48. Jahrestagung ÖGP - 8th Jahrestagung OGTC; SEP 26-28, 2024; Vienna, Austria. [Poster]
Web of Science

Lami, K; Torikoshi, Y; Nakama, S; Ota, N; Yamaoka, S; Brcic, L; Fukuoka, J Enhancing Diagnostic Standardization in Lung Adenocarcinoma: Leveraging Multiple Artificial Intelligences for Consensus-Based Pathological Diagnosis
LAB INVEST. 2024; 104(3): S1589-S1590. [Poster]
Web of Science

Mathian, E; Drouet, Y; Sexton-Oates, A; Papotti, M; Pelosi, G; Vignaud, JM; Brcic, L; Mansuet-Lupo, A; Acala, N; Fernandez-Cuesta, L; Lantuejoul, S; Foll, M Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumors in the lungNENomics project
J NEUROENDOCRINOL. 2024; 36: 34-34. [Poster]
Web of Science

Runtsch, M; Kindler, O; Eichmann, T; Santiso, A; Maitz, K; Brcic, L; Lindenmann, J; Kargl, J The tumor microenvironment drives mitochondrial metabolic reprogramming in neutrophils during non-small cell lung cancer
EUR J IMMUNOL. 2024; 54: 176-176.-7th European Conference of Immunology; SEP 01-04, 2024; Dublin, IRELAND. [Oral Communication]
Web of Science

Sano, H; Okoshi, E; Tachibana, Y; Brcic, L; Bychkov, A; Fukuoka, J Machine Learning-Based Classification Model to Address Diagnostic Challenges in TBLB
LAB INVEST. 2024; 104(3): S1953-S1954. [Poster]
Web of Science

Shintaro, S; Zaizen, Y; Augustyniak, J; Berezowska, S; Brcic, L; Carneiro, A; Fabro, A; Hebisawa, A; Kern, I; Koyama, R; Larsen, B; Marchevsky, A; Schneider, F;Kunugi, S; Fukuoka, J Standardization of granulomas in diffuse lung diseases.
36th European Congress of Pathology; SEP 7-11, 2024; Florence, ITALY. 2024. [Oral Communication]

Stanzel, S; Brcic, L; Pernthaler, B; Schmid, J; Plhak, E; Aigner, RM ¹⁸F-FDG PET/CT and 68Ga-DOTA-NOC PET/CT in large cell neuroendocrine carcinoma of the lung with myocardial metastasis mimicking primary heart tumor
EUR J NUCL MED MOL I. 2024; 51: S848-S848. [Poster]
Web of Science

Stanzel, S; Brcic, L; Pernthaler, B; Schmid, J; Plhak, E; Aigner, RM 18F-FDG PET/CT and 68Ga-DOTA-NOC PET/CT in large cell neuroendocrine carcinoma of the lung with myocardial metastasis mimicking primary heart tumor.
Eur J Nucl Med Mol Imaging. 2024; 51(Suppl1):S848-S848.-37th Annual Congress of the European Association of Nuclear Medicine EANM'24; OCT 19-23, 2024; Hamburg, GERMANY. [Poster]
FullText

Zacharias, M; Thüringer, A; Brcic, L; Gorkiewicz, G Cryptococcal inflammatory pseudotumour of the lung - a diagnostic pitfall
VIRCHOWS ARCH. 2024; 485: S514-S515. [Poster]
Web of Science

Blaauwgeers, JLG; Filipello, F; Lissenberg-Witte, B; Minami, Y; Noguchi, M; Vreuls, W; von der Thusen, J; Le Quesne, J; Papotti, M; Timens, W; Sansano, I; Moore, D; Berezowska, S; Ryska, A; Pelosi, G; Brcic, L; Jones, K; Motoi, N; Nakatani, Y; Kuempers, C; Hofman, P; Hofman, V; Dale, V; Rossi, G; Ambrosi, F; Matsubara, D; Ishikawa, Y; Weynand, B; Calabrese, F; Kern, I; Perner, S; Leonte, D; Nicholson, S; Flieder, D; Ooft, M; Brinkhuis, M; Bulkmans, N; Al-Janabi, S; Mutka, A; Dacic, S; Beasley, MB; Arrigoni, G; Britstra, R; Hager, H; Schonau, A; Pezzuto, F; Thunnissen, E Is Collapsed Adenocarcinoma in Situ Recognized in the WHO Classification? A Reproducibility Study with an Alternative Diagnostic Approach.
LAB INVEST. 2023; 103(3): S1593-S1593. [Poster]
Web of Science

Brcic, L Fallpräsentationen zum Thema Thymustumore und neuroendokrine Tumore.
ÖGPath Herbsttagung 2023; SEP 28-30, 2023; 2023. [Oral Communication]

Brcic, L Separating benign from malignant lesions.
16th International conference of the International Mesothelioma Interest Group (iMig); JUN 26-28, 2023; Lille, FRANCE. 2023. [Oral Communication]

Brcic, L Molecular pathology of NSCLC – mandatory tests – when, how, for whom?
Summer School in Oncology; JUNE 12-15, 2023; Bucharest, ROMANIA. 2023. [Oral Communication]

Brcic, L Die Rolle des Pathologen bei Diagnose und Therapiemonitoring.
Lung Cancer Expert Meeting; JUN 30- JUL 1, 2023; Dürnstein, AUSTRIA. 2023. [Oral Communication]

Brcic, L Role of AI in lung tumor pathology today and in the future.
7th Graz Lung days; NOV 23-24, 2023; Graz, AUSTRIA. 2023. [Oral Communication]

Brcic, L Aktuelle und zukünftige Biomarker aus Sicht der Pathologie.
Patho-Melange. PATHO MEETS CLINIC.; NOV 22, 2023; Graz, AUSTRIA. 2023. [Oral Communication]

Brcic, L Biomarker in der Thoraxpathologie.
47. Jahrestagung der Österreichischen Gesellschaft für Pneumologie und der Österreichischen Gesellschaft für Thoraxchirurgie; OCT 23-25,2023; Graz, AUSTRIA. 2023. [Oral Communication]

Brcic, L Molekularpathologische Diagnostik des NSCLC 2023.
Oncology Talks; APR 19, 2023; Wels, AUSTRIA. 2023. [Oral Communication]

Brcic, L Molecular Diagnostics in Mesothelioma.
Molecular Diagnostics Training School; FEB 20-22, 2023; Vienna, AUSTRIA. 2023. [Oral Communication]

Brcic, L Slide seminar: Case 1-5.
SHAPING A WORLD-CLASS UNIVERSITY: WINTER SCHOOL 2023 Occupational diseases: focus on pulmonary/thoracic pathology; FEB 13-17, 2023; Padova, ITALY. 2023. [Oral Communication]

Brcic, L Pathological diagnosis of occupational lung diseases what sources?/what tools?
SHAPING A WORLD-CLASS UNIVERSITY: WINTER SCHOOL 2023 Occupational diseases:focus on pulmonary/thoracic pathology; FEB 13-17, 2023; Padova, ITALY. 2023. [Oral Communication]

Brcic, L Digital Pathology & die Rolle der AI: Zukunft oder bereits Realität?
20. Expert Meeting: Zielgerichtete NSCLC Therapie heute und morgen.; DEC 15, 2023; Vienna, AUSTRIA. 2023. [Oral Communication]

Brcic, L Treibermutiertes NSCLC: Möglichkeiten der Diagnostik & Diskussion.
Treibermutiertes NSCLC; NOV 29, 2023; Leoben, AUSTRIA. 2023. [Oral Communication]

Brcic, L AI als Zukunft der Pathologie?
Lungenkarzinom – facts & consequences; JUN 21, 2023; Graz, AUSTRIA. 2023. [Oral Communication]

Brcic, L Pitfalls in non-neoplastic pulmonary pathology - slide seminar.
Golnik Symposium 2023; APR 28-29, 2023; Vila Vipolze, SLOVENIA. 2023. [Oral Communication]

Brcic, L Case presentation: PAH/PVOD.
2023 Brazilian National Course in Pulmonary Radiopathology; MAY 5-6, 2023; BRAZIL. 2023. [Oral Communication]

Brcic, L Case presentation 1: NSIP.
2023 Brazilian National Course in Pulmonary Radiopathology; MAY 5-6, 2023; BRAZIL. 2023. [Oral Communication]

Brcic, L Biomarkertestung-der Weg für personalisierte Therapie von HNSCC Patient:innen.
Onco Road Show; MAY 12, 2023; Vienna, AUSTRIA. 2023. [Oral Communication]

Brcic, L Basics in ILD Pathology.
Train the Trainee. Lung Sonography Course.; NOV 28, 2023; Graz, AUSTRIA. 2023. [Oral Communication]

Brcic, L HNO- und Oralpathologie.
Pathology Future Academy: Intensivseminar für Klinische Pathologie.; NOV 26-28, 2023; Seggau, AUSTRIA. 2023. [Oral Communication]

Brcic, L Pathological approach to HP.
2023 Brazilian National Course in Pulmonary Radiopathology; MAY 5-6, 2023; BRAZIL. 2023. [Oral Communication]

Brcic, L My approach to the pathological diagnosis of asbestos-related lung diseases other than mesothelioma and asbestosis.
SHAPING A WORLD-CLASS UNIVERSITY: WINTER SCHOOL 2023 Occupational diseases: focus on pulmonary/thoracic pathology; FEB 13-17, 2023; Padova, ITALY. 2023. [Oral Communication]

Brcic, L Update zur Diagnostik des NSCLCs.
Lung Cancer Insight Steiermark; Jan 17, 2023; Graz, AUSTRIA. 2023. [Oral Communication]

Brcic, L; John, N; Schlintl, V; Zacharias, M; Kalson, L; Prein, K; Lax, SF; Lindenmann, J; Absenger, G; Terbuch, A Longitudinal analysis of PD-L1 expression in patients with relapsed NSCLC.
The 69th Autumn Anual Meeting of the Japanese Society of Pathology; NOV 09-10, 2023; Kurume, JAPAN. 2023. [Poster]

Foris, V; Brcic, L; Eichstaedt, CA; Kovacs, G; Douschan, P; Zeder, K; Sassmann, T; Hinderhofer, K; Grunig, E; Olschewski, A; Olschewski, H Pulmonary Vascular Remodeling May Precede Pulmonary Arterial Pressure Elevation in Pulmonary Veno-occlusive Disease- A Report of Three Cases
AM J RESP CRIT CARE. 2023; 207: -International Conference of the American-Thoracic-Society (ATS); MAY 19-24, 2023; Washington, DC. [Poster]
Web of Science

He, K; Absenger, G; Pickering, C; Guerrier, C; Dhar, C; Xu, G; Hartness, J; Rice, R; Schwarz, F; Serie, D; Hommes, D; Brcic, L Decoding the glycan code: Pioneering early detection of non-small cell lung cancer through glycoproteomics
ANN ONCOL. 2023; 34: S724-S724. Doi: 10.1016/j.annonc.2023.09.2330 [Poster]
Web of Science FullText FullText_MUG

Myronenko, O; John, N; Foris, V; Brcic, L; Wöhlkonig, C; Wurm, R; Olschewski, A; Olschewski, H Computational approach in phenotyping of monocyte/macrophage subsets in bronchoalveolar lavage fluid of COPD patients: prospective study
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(19-20):565-566.-47. Jahrestagung der ÖGP - 7. Jahrestagung der ÖGTC; OCT 23-25, 2023; Graz, Austria. [Poster]
Web of Science

Nei, Y; Uegami, W; Attanoos, R; Cavazza, A; Marchevsky, AM; Schneider, F; Augustyniak, JW; Almutrafi, A; Fabro, AT; Brcic, L; Roden, AC; Smith, ML; Moreira, A; Kataoka, K; Kondoh, Y; Fukuoka, J Explainable artificial intelligence model, MIXTURE, predicts equivalent prognostic value of UIP to worldwide expert pathologists
RESPIROLOGY. 2023; 28: 18-20.
Web of Science

Runtsch MC, Kindler O, Hooftman A, Wadhwa R, Zhang Y, McGettrick A, Hansbro P, Wang C, Angiari S, Kargl J, O'Neill L “Itaconate suppresses alternative activation of macrophages and alters responses in the lung tumor microenvironment
5th International Conference on ImmunoMetabolism: Molecular and Cellular Immunology of Metabolism ; May 2023; Chania, Greece. 2023. [Poster]

Runtsch MC, Roth J, Kindler O, Santiso A, Maitz K, Brcic L, Lindenmann J, Kargl J Lung tumor neutrophils undergo metabolic reprogramming during NSCLC
The Austrian Society for Allergology and Immunology Meeting; September 2023; Linz, Austria. 2023. [Poster]

Schlagenhaufen, S; Pfleger, A; Maier, A; Brcic, L; Singer, F; Eber, E A girl with pneumonia and an eye-catching chest x-ray
WIEN KLIN WOCHENSCHR. 2023; 135(19-20): 583-583. [Poster]
Web of Science

Thunnissen, E; Blaauwgeers, H; Filipello, F; Lissenberg-Witte, B; Minami, Y; Noguchi, M; Le Quense, J; Papotti, MG; Flieder, D; Pelosi, G; Sansano, I; Berezowska, S; Ryska, A; Brcic, L; Motoi, N; Nakatani, Y; Kuempers, C; Hofman, P; Hofman, V; Dale, VG; Rossi, G; Ambrosi, F; Matsubara, D; Ishikawa, Y; Weynand, B; Calabrese, F; Pezzuto, F; Kern, I; Nicholson, S; Mutka, AL; Dacic, S; Beasley, MB; Arrigoni, G; Timens, W; Ooft, M; Brinkhuis, M; Bulkmans, N; Britstra, R; Vreuls, W; Jones, K; von der Thüsen, J; Hager, H; Perner, S; Moore, D; Leonte, DG; Al-Janabi, S; Schonau, A; Stenzinger, A; Kazdal, D Invasion or No Invasion, That′s the Question. A Large Reproducibility Study in Pulmonary Adenocarcinoma, Supporting a Modified Classification
J THORAC ONCOL. 2023; 18(11): S35-S36. [Poster]
Web of Science

Thurner, D; Kindler, K; Pondorfer-Schäfer, P; Weiland, T; Walla, K; Moser, U; Kiss, P; Brcic, L; Andrianakis, A; Maitz, E; Pock, J; Habenbacher, M; Magyar, M; Tomazic, P.V. Quality of the TNM classification in hypopharyngeal squamous cell cancer at the head and neck tumor board of the Medical University of Graz.
67. Österreichischer HNO-Kongress 2023; SEP 27-30, 2023; Hofburg Vienna, AUSTRIA. 2023. [Poster]

Thurnher, D; Walla, K; Pondorfer-Schäfer, P; Kircher, L; Weiland, T; Brcic, L; Tomazic, P.V.; Kindler, K; Pock, J; Maitz, E; Habenbacher, M 146. Epidemiology of oropharyngeal carcinoma in a single-centre.
67. Österreichischer HNO-Kongress 2023; SEP 27-30, 2023; Hofburg Vienna, AUSTRIA. 2023. [Poster]

Thurnher, D; Weiland, T; Zgubic, J; Brcic, L Überlebensvorteil bei serologischer IgA Dominanz gegenüber IgA AK gegen HPV L1 bei HPV pos. Oropharynxkarzinomen
67. Österreichischer HNO-Kongress 2023; SEP 27-30, 2023; Hofburg VIENNA, AUSTRIA. 2023. [Oral Communication]

Zeder, K; Marsh, LM; Avian, A; Brcic, L; Birnhuber, A; Douschan, P; Foris, V; Sassmann, T; Hoetzenecker, K; Boehm, P; Kwapiszewska, G; Olschewski, A; Olschewski, H; Kovacs, G Compartment-specific Remodeling of End-stage Chronic Obstructive Pulmonary Disease Patients With Severe Pulmonary Hypertension Based on Histological Lung Tissue Samples
AM J RESP CRIT CARE. 2023; 207: -International Conference of the American-Thoracic-Society (ATS); MAY 19-24, 2023; Washington, DC. [Oral Communication]
Web of Science

Baumgartner, N; Brcic, L; Imlinger C; Mostbeck, G; Tagavi, S ILD Board.
46. Jahrestagung der Österreichischen Gesellschaft für Pneumonologie/ der Österreichischen Gesellschaft für Thoraxchirurgie.; SEP 29 - OCT 1, 2022; Salzburg, AUSTRIA. 2022. [Oral Communication]

Brcic, L Primary lung cancer types and overview of lung metastases.
IO Foundation Course.; APR 23, 2022; Vienna, AUSTRIA. 2022. [Oral Communication]

Brcic, L Pathology Workshop: Virtual Microscopy Session.
Virtual ITMIG2022 Annual Meeting; SEP 29 - OCT 2; POLAND. 2022. [Onlinepräsentation]

Brcic, L Pathology of mesothelioma and trial of AI for PD-L1 evaluation.
Presentation at Nagasaki University; NOV 8, 2022; Nagasaki, JAPAN. 2022. [Oral Communication]

Brcic, L Genetic profiling of small cell carcinoma and clinical implications.
XXXIV International Congress of the International Academy of Pathology ; OCT, 11-15, 2022; Sydney, AUSTRALIA. 2022. [Oral Communication]

Brcic, L Lunge und Pleura.
Pathology Future Academy-Intensivseminar für Klinsche Pathologie; NOV 24-26, 2022; Seggau, AUSTRIA. 2022. [Oral Communication]

Brcic, L Pathological approach to HP.
Presentation at Nagasaki University; NOV 9, 2022; Nagasaki, JAPAN. 2022. [Oral Communication]

Brcic, L Thymic and Mediastinal Pathology: Germ cell tumours of the mediastinum. Case 1.
34th European Congress of Pathology; SEP 3-7, 2022; Basel, SWITZERLAND. 2022. [Oral Communication]

Brcic, L Molecular changes in pleural mesothelioma.
34th European Congress of Pathology; SEP 3-7, 2022; Basel, SWITZERLAND. 2022. [Oral Communication]

Brcic, L Nutzen der Liquid Biopsy/ctDNA/Konzept der minimal residual disease im early stage NSCLC.
12. Bronhuskarzinom-Workshop; NOV 25-26, 2022; Vienna, AUSTRIA. 2022. [Oral Communication]

Brcic, L Practical relevance of molecular changes in mesothelioma.
PATHOLOGY ACP LECTURE SERIES. SINGAPORE GENERAL HOSPITAL.; DEC 5, 2022; SINGAPORE. 2022. [Oral Communication]

Brcic, L Genetische Diagnostik bei Lungentumoren.
6. Grazer Lungentag; NOV 23, 2022; Graz, AUSTRIA. 2022. [Oral Communication]

Brcic, L Rare Molekular Drivers beim Lungenkarzinom - Diagnostische und prädiktive Tests.
FORTBILDUNGSREIHE ONKOLOGIE: HOW I TREAT – Rare Molecular Drivers beim Lungenkarzinom; MAR 22, 2022; Feldkirch, AUSTRIA. 2022. [Oral Communication]

Brcic, L MCL-1 in lung cancer.
1. Innsbruck – Graz Lung Cancer Workshop; MAR 4, 2022; Werfenweng, AUSTRIA. 2022. [Oral Communication]

Brcic, L Molecular Diagnostics in Mesothelioma.
Molecular Diagnostics Training School; FEB 21-23, 2022; Vienna, AUSTRIA. 2022. [Onlinepräsentation]

Brcic, L Das Maligne Pleuramesotheliom aus Sicht des Pathologen.
Webinar/ Fortschritte beim Malignen Pleuramesotheliom – eine multidisziplinäre Betrachtung; MAR 1, 2022; Vienna, AUSTRIA. 2022. [Onlinepräsentation]

Brcic, L Speicheldrüsenähnliche Tumore der Lunge.
PATHOLOGIE.RECHT.2022; JAN 9-12, 2022; Zauchensee. 2022. [Oral Communication]

Brcic, L Update Mesotheliomregister Österreich.
PATHOLOGIE.RECHT.2022; JAN 9-12, 2022; Zauchensee. 2022. [Oral Communication]

Brcic, L Update zur Diagnostik des NSCLCs.
LUNG CANCER INSIGHT STEIERMARK; MAR 16, 2022; Graz, AUSTRIA. 2022. [Oral Communication]

Brcic, L Spindle cell tumors in lung biopsies.
6th Pannonia Congress of Pathology; MAY 18-21, 2022; Tále – Low Tatras, SLOVAKIA. 2022. [Oral Communication]

Brcic, L. The 2021 WHO Classification of Lung Tumours- what has changed since 2015?
Frühjahrstagung der ÖGPath; MAR 11-12,2022; Vienna, AUSTRIA. 2022. [Oral Communication]

Brcic, L; Zacharias, M; Konjic, S; Kashofer, K; Absenger, G; Jost, PJ; Wurm, R; Lindenmann, J; Terbuch, A Molecular testing in lung squamous cell carcinoma using DNA- and RNA-based next-generation sequencing: A singlecenter experience
ANN ONCOL. 2022; 38(9): S1557-S1557. Doi: 10.1016/j.annonc.2022.10.344 [Poster]
Web of Science FullText FullText_MUG

Honeder, SE; Gindlhuber, J; Tomin, T; Schittmayer, M; Brcic, L; Birner-Gruenberger, R Activity-based proteomic profiling reveals reduction of lipid hydrolase activity levels in non-small cell lung cancer tumors
MOL CELL PROTEOMICS. 2022; 21(8): S69-S69. Doi: 10.1016/j.mcpro.2022.100377 [Poster]
Web of Science FullText FullText_MUG

Illini, O; Fabikan, H; Hochmair, MJ; Weinlinger, C; Krenbek, D; Brcic, L; Setinek, U; Terbuch, A; Absenger, G; Konji, S; Valipour, A Characteristics and treatment outcomes in advanced stage non-small cell lung cancer patients with KRAS G12C mutation
WIEN KLIN WOCHENSCHR. 2022; 134(19-20):727-728.
Web of Science

Kindler, K; Pondorfer-Schäfer, P; Weiland, T; Walla, K; Moser, U.C.; Kiss, P; Brcic, L; Maitz, E; Pock, J; Magyar, M; Tomazic, P.V.; Thurnher, D Behandlung und Überlebensrate von Patienten mit Hypopharynxkarzinomen: Eine 10-Jahres Single-Center Studie.
66. Österreichischer HNO-Kongress 2022; SEP 21-23, 2022; Graz, AUSTRIA. 2022. [Poster]

Kuhnelt-Leddihn, M; Wurm, R; Talakic, E; Brcic, L Meslazine-induced hypersensitivity pneumonitis
WIEN KLIN WOCHENSCHR. 2022; 134(19-20):735-735. [Poster]
Web of Science

Lang, C; Megyesfalvi, Z; Szeitz, B; Lantos, A; Woldmar, N; Valko, Z; Schwendenwein, A; Oberndorfer, F; Barany, N; Paku, S; Laszlo, V; Kiss, H; Bugyik, E; Ferencz, B; Dezso, K; Lohinai, Z; Moldvay, J; Fillinger, J; Galffy, G; Rivard, C; Hirsch, FR; Brcic, L; Popper, H; Kern, I; Kovacevic, M; Skarda, J; Mittak, M; Szasz, AM; Pizzatti, L; Bogos, K; Hoda, MA; Hoetzenecker, K; Marko-Varga, G; Horvatovics, P; Renyi-Vamos, F; Klikovits, T; Schelch, K; Rezeli, M; Dome, B Subtype-specific transcription factors are clinically relevant and show distinct therapeutic vulnerabilities in human small cell lung cancer
EUR RESPIR J. 2022; 60: Doi: 10.1183/13993003.congress-2022.3828
Web of Science FullText FullText_MUG

Lindenmann, J; Fink-Neuboeck, N; Fediuk, M; Porubsky, Ch; Absenger, G; Mykoliuk, I; Brcic, L; Anegg, U; Maier, A; Jost, P; Smolle, J; Smolle-Juettner, FM Recurrence and survival following surgery of T3 esophageal carcinoma with curative intent. Role of circumferential resection margin.
European Surgrey- ACA. 2022; 54: 50-50.-63. Österreichischer Chirurgenkongress; JUN 15-17, 2022; Graz, AUSTRIA. [Oral Communication]

Mairinger, FD; Mathilakathu, A; Wessolly, M; Mairinger, E; Beckert, H; Kreidt, D; Brcic, L; Steinborn, J; Greimelmaier, K; Wohlschlaeger, J; Schmid, KW; Borchert, S Cancer-associated fibroblasts regulate kinase activity in mesothelioma cell lines via paracrine signaling and thereby dictate cell faith and behavior.
ONCOL RES TREAT. 2022; 45(SUPPL 3):260-260.-35. Deutscher Krebskongress; NOV 13-16, 2022; Berlin, GERMANY. [Poster]
Web of Science

Megyesfalvi, Z; Barany, N; Lantos, A; Valko, Z; Pipek, O; Lang, C; Schwendenwein, A; Oberndorfer, F; Paku, S; Ferencz, B; Dezso, K; Fillinger, J; Lohinai, Z; Moldvay, J; Galffy, G; Rezeli, M; Rivard, C; Hirsch, F; Brcic, L; Popper, H; Kern, I; Kovacevic, M; Skarda, J; Mittak, M; Marko-Varga, G; Bogos, K; Renyi-Vamos, F; Hoda, MA; Klikovits, T; Hoetzenecker, K; Schelch, K; Laszlo, V; Dome, B Molecular Subtypes of Surgically Resected Small Cell Lung Cancer: Expression Pattern and Prognostic Relevance
J THORAC ONCOL. 2022; 17(9): S43-S44. [Oral Communication]
Web of Science

Mykoliuk, I; Lindenmann, J; Fink-Neuboeck, N; Fediuk, M; Porubsky, Ch; Terbuch, A; Absenger, G; Brcic, L; Anegg, U; Maier, A; Smolle, J; Smolle-Juettner, FM Perioperative complications in esophagectomy for carcinoma are correlated to a higher recurrence rate.
European Surgery- ACA. 2022; 54: 67-68.-63. Österreichischer Chirurgenkongress; JUN 15-17, 2022; Graz, AUSTRIA. [Oral Communication]

Neururer, M; Brcic, L; Eidenhammer, S; Popper, H Expression of phagocytosis markers and phagocytosis inhibitors in Usual Interstitial Pneumonia (UIP).
VIRCHOWS ARCH. 2022; 481(SUPPL 1):S27-S27.-34th European Congress of Pathology; SEP 3-7, 2022; Basel, SWITZERLAND. [Oral Communication]
Web of Science

Plass, M; Dacic, S; Kern, I; Zacharias, M; Popper, H; Fukuoka, J; Kargl, M; Muller, H; Murauer, C; Brcic, L A Comparative Study of PD-L1 Scoring: Humans versus AI
J THORAC ONCOL. 2022; 17(9): S515-S515. [Poster]
Web of Science

Sarsembayeva, A; Kienzl, M; Gruden, E; Ristic, D; Brcic, L; Kargl, J; Schicho, R The cannabinoid receptor 2 and its role in tumor progression in non-small cell lung cancer
25th Scientific Symposium of the Austrian Pharmacological Society (APHAR) ; Sep 23-24, 2022; Graz, Austria. 2022. [Oral Communication]

Sarsembayeva, A; Kienzl, M; Gruden, E; Ristic, D; Maitz, K; Hasenoehrl, C; Taschler, U; Valadez-Cosmes, P; Kindler, O; Bärnthaler, T; Brcic, L; Kargl, J; Schicho, R Cannabinoid receptor 2 expression in cells of the tumor microenvironment determines tumor burden of non-small cell lung cancer
Doctoral day 2022 at the Medical University of Graz; Feb 10, 2022; Graz, Austria. 2022. [Poster]

Strasser, A, Pondorfer-Schäfer, P; Mutz-Rabl, CH; Walla, K; Weiland, T; Brcic, L; Tomazic, P.V.; Thurnher, D Checkpoint-Inhibitoren in der Schwangerschaft – Fallbericht und Literaturrecherche seltener Umstände.
66. Österreichischer HNO-Kongress 2022; SEP 21-23, 2022; Graz, AUSTRIA. 2022. [Poster]

Walla, K; Pondorfer-Schäfer, P; Weiland, T; Maitz, E; Kiss, P; Brcic, L; Hammer, G; Tomazic, P.V.; Thurnher, D Clinical Outcome of Total Laryngectomy of a single centre.
66. Österreichischer HNO-Kongress 2022; SEP 21-23, 2022; Graz, AUSTRIA. 2022. [Poster]

Weiland, T; Pondorfer-Schäfer, P; Kiss, P; Tomazic, P.V.; Wolf, A; Moser, U.C.; Andrianakis, A; Walla, K; Maitz, E; Brcic, L; Thurnher, D Low-grade myofibroblastisches Sarkom: Fallbericht und Literature Review einer seltenen Tumorentität des Larynx.
66. Österreichischer HNO-Kongress 2022; SEP 21-23, 2022; Graz, AUSTRIA. 2022. [Poster]

Weiland, T; Pondorfer-Schäfer, P; Tomazic, P.V.; Wolf, A; Kiss, P; Moser, U.C.; Andrianakis, A; Brcic, L; Thurnher, D HPV16 serology for post-treatment monitoring in patients with oropharyngeal carcinoma.
66. Österreichischer HNO-Kongress 2022; SEP 21-23, 2022; Graz, AUSTRIA. 2022. [Poster]

Wessolly, M; Mathilakathu, A; Mairinger, E; Nath, A; Beckert, H; Kreidt, D; Klopp, N; Hegedus, B; Steinborn, J; Hager, T; Walter, RFH; Christoph, DC; Kollmeier, J; Wohlschlaeger, J; Mairinger, T; Brcic, L; Borchert, S; Schmid, KW; Mairinger, FD Signaling pathways linked to activity of cancer-associated fibroblasts lead to cancer progression and increased tumor cell motility in malignant pleural mesothelioma.
ONCOL RES TREAT. 2022; 45(SUPPL 3):257-258.-35. Deutscher Krebskongress; NOV 13-16, 2022; Berlin, GERMANY. [Poster]
Web of Science

Zacharias, M; Konjic, S; Absenger, G; Hochmair, MJ; Fabikan, H; Weinlinger, C; Illini, O; Jost, PJ; Schlintl, V; Wurm, R; Lindenmann, J; Fediuk, M; Brcic, L; Terbuch, A Clinicopathological Features of Rare but Targetable Mutations in Surgically Resected Lung Carcinomas
J THORAC ONCOL. 2022; 17(9): S201-S202. [Poster]
Web of Science

Zeder, K; Marsh, L; Avian, A; Brcic, L; Birnhuber, A; Douschan, P; Foris, V; Sassmann, T; Hotzenecker, K; Bohm, P; Kwapiszewska, G; Olschewski, H; Kovacs, G Remodeling of pulmonary arteries, airways and parenchyma in end-stage COPD patients with severe pulmonary hypertension
WIEN KLIN WOCHENSCHR. Abstracts 46. Jahrestagung der Österreichischen Gesellschaft für Pneumologie 6. Jahrestagung der Österreichischen Gesellschaft für Thoraxchirurgie. 2022; 134(19-20):724-724.-46. Jahrestagung der Österreichischen Gesellschaft für Pneumologie 6. Jahrestagung der Österreichischen Gesellschaft für Thoraxchirurgie; SEP 29 - OCT 1, 2022; Salzburg, AUSTRIA. [Oral Communication]
Web of Science

Zeder, K; Marsh, LM; Avian, A; Brcic, L; Birnhuber, A; Douschan, P; Foris, V; Sassmann, T; Bohm, P; Hoetzenecker, K; Kwapiszewska, G; Olschewski, H; Kovacs, G End-stage COPD patients with severe pulmonary hypertension have less airspace enlargement in histologic samples of explanted lungs
EUR RESPIR J. 2022; 60: Doi: 10.1183/13993003.congress-2022.2013 [Oral Communication]
Web of Science FullText FullText_MUG

Zgubic, JA; Zacharias, M; Wurm, R; Terbuch, A; Brcic, L Predictive and prognostic relevance of PD-L1 and TIGIT expression in patients with non-small cell lung carcinoma treated with immunotherapy
HISTOPATHOLOGY. 2022; 81: 170-170. [Poster]
Web of Science

Brcic, L Pathologie: Differenzierung zwischen Karzinoiden.
45. Jahrestagung der Österreichischen Gesellschaft für Pneumologie/der Österreichischen Gesellschaft für Thoraxchirurgie; OCT 6-8, 2021; AUSTRIA. 2021. [Oral Communication]

Brcic, L Do NTRK-positive lung tumors exist?
Spring meeting ÖGPath/IAP Austria and joint meeting with IAP Arab Division; APR 8-10, 2021; Vienna, AUSTRIA. 2021. [Oral Communication]

Brcic, L Molecular Diagnostics in Mesothelioma.
2021 Molecular Diagnostics Training School ; FEB 08-10, 2021; AUSTRIA. 2021. [Onlinepräsentation]

Brcic, L Druggable Biomarkers: Now & Next.
18. Expert Meeting; OCT 22, 2021; 2021. [Oral Communication]

Brcic, L; Le Stang, N; Gallob, F; Pissaloux, D; Sequeiros, R; Tirode, F; Paindavoine, S; Pairon, JC; Dacic, S; Girard, N; Churg, A; MESOPATH College experts; Galateau Salle, F Is MTAP expression an adequate surrogate of CDKN2A (p16) homozygous deletion? Cross-validation from the experience of the MESOPATH Reference Center.
15th Meeting of the International Mesothelioma Interest Group; MAY 7-9, 2021; Brisbane, AUSTRALIA. 2021. [Oral Communication]

Fediuk, M; Fink-Neuböck, N; Porubsky, C; Terbuch, A; Douschan, P; Koutp, A; Brcic, L; Maier, A; Smolle, J; Smolle-Jüttner, FM Salvage pneumonectomy in lung cancer with septic complication carries high perioperative risk.
WIEN KLIN WOCHENSCHR. 2021; 133(19-20):1078-112.-45. Jahrestagung der Österreichischen Gesellschaft für Pneumologie (ÖGP)/ 5. Jahrestagung der Österreichischen Gesellschaft für Thoraxchirurgie (OGTC); OCT 6-8, 2021; AUSTRIA. [Onlinepräsentation]

Lami, K; Attanoos, R; Beasley, MB; Berezowska, S; Brcic, L; Cavazza, A; English, J; Fabro, A; Ishida, K; Kashima, Y; Larsen, B; Marchevsky, A; Roden, A; Schneider, F; Smith, M; Tabata, K; Takano, A; Tanaka, T; Bychkov, A; Fukuoka, J Extracting Morphological Features to Differentiate Histological Subtypes of Lung Adenocarcinoma: An Attempt to Improve Diagnostic Accuracy by Using a Deep Learning Algorithm
MODERN PATHOL. Meeting Abstracts. 2021; 34(SUPPL 2):1116-1117.-USCAP 110th Annual Meeting; MAR 13-18, 2021; Virtuell, USA. [Poster]
Web of Science

Lami, K; Attanoos, R; Beasley, MB; Berezowska, S; Brcic, L; Cavazza, A; English, J; Fabro, A; Ishida, K; Kashima, Y; Larsen, B; Marchevsky, A; Roden, A; Schneider, F; Smith, M; Tabata, K; Takano, A; Tanaka, T; Bychkov, A; Fukuoka, J Extracting Morphological Features to Differentiate Histological Subtypes of Lung Adenocarcinoma: An Attempt to Improve Diagnostic Accuracy by Using a Deep Learning Algorithm
LAB INVEST. Meeting Abstracts. 2021; 101(SUPPL 1):1116-1117.-USCAP 110th Annual Meeting; MAR 13-18, 2021; Virtuell, USA. [Poster]
Web of Science

Opitz, I; Ruschoff, JH; Haberecker, M; Tsourti, Z; Nackaerts, K; Ampollini, L; De Perrot, M; Brcic, L; Nadal, E; Gray, S; Aerts, J; Verbeken, E; Silini, E; Zaeimi, F; Samarzija, M; Llatjos, R; Tsimpoukis, S; Von der Thusen, J; Finn, S; Monkhorst, K; Marti, N; Dimopoulou, G; Kammler, R; Peters, S; Baas, P; Stahel, R Phosphorylated Ribosomal Protein S6, Correlation With Characteristics and Clinical Outcome in Patients With MPM: Results from ETOP Mesoscape
J THORAC ONCOL. Abstracts Book. 2021; 16(3):S152-S152.-IASLC 2020 World Conference on Lung Cancer; JAN 28-31, 2021; Virtuell. [Poster]
Web of Science

Popper, H; Zacharias, M; Brcic, L; Marsh, L; Lehrach, H; Schutte, M; Kwapiszewska, G; Timmermann, B; Kashofer, K; Nerlich, A; Regitnig, P; Kenner, L; Zatloukal, K Different types of immune system regulations in severe Coronavirus disease 2019
VIRCHOWS ARCH. 2021; 479(SUPPL 1):S50-S50. [Onlinepräsentation]
Web of Science

Smolle, E; Leko, P; Stacher-Priehse, E; Brcic, L; El-Heliebi, A; Hofmann, A; Quehenberger, F; Hrzenjak, A; Popper, HH; Olschewski, H; Leithner, K Distribution and prognostic significance of gluconeogenesis and glycolysis in human lung cancer
VIB Conferences: Tumor Heterogeneity, Plasticity and Therapy; MAY 5-6, 2021; Virtual. 2021. [Poster]

Smolle, E; Leko, P; Stacher-Priehse, E; Brcic, L; El-Heliebi, A; Hofmann, L; Quehenberger, F; Hrzenjak, A; Popper, H; Olschewski, H; Leithner, K Expression Pattern and Prognostic Significance of Gluconeogenesis Enzymes in Lung Cancer.
J THORAC ONCOL. 2021; 16(3):S550-S550. [Poster]
Web of Science

Thurnher, D; Pondorfer-Schäfer, P; Strasser, A; Weiland, T; Wolf, A; Brcic, L; Moser, U; Lukasiak, K; Kiss, P Impact of 8th TNM classification on staging and therapy in oropharyngeal squamous cell carcinoma.
65. Österreichischer HNO-Kongress 2021; SEP 22-26, 2021; Innsbruck, AUSTRIA. 2021. [Poster]

Thurnher, D; Weiland, T; Pondorfer-Schäfer, P; Kiss, P; Vasicek, S; Tomazic, PV; Wolf, A; Moser, U; Holzmeister, C; Andrianakis, A; Kangler, G; Graupp, M; Brcic, L Larynx & Pharynx - Funktion und Pathologie: DRH1 - Evaluierung eines neuen blutbasierten HPV16-Antikörperassays.
65. Österreichischer HNO-Kongress 2021; SEP 22-26, 2021; Innsbruck, AUSTRIA. 2021. [Oral Communication]

Weiland, T; Pondorfer, P; Kiss, P; Vasicek, S; Tomazic, PV; Wolf, A; Moser, U; Holzmeister, C; Andrianakis, A; Kangler, G; Graupp, M; Brcic, L; Thurnher, D DRH1 - Evaluierung eines neuen blutbasierten HPV16-Antikörperassays.
Konferenzband. 2021; -65. Österreichischer HNO-Kongress; SEPT 22-26, 2021; Innsbruck, AUSTRIA. [Oral Communication]

Brcic, L Alte und Neue Biomarker und deren Testung.
Lung Cancer Insight Steiermark; JAN 16, 2020; Graz, AUSTRIA. 2020. [Oral Communication]

Brcic, L COVID-19: from the pathological point of view.
LBI LVI Retreat; SEP 17-18, 2020; Ehrenhausen, AUSTRIA. 2020. [Oral Communication]

Brcic, L Neue Marker in der Mesotheliomdiagnostik. MesoViBe.
Frühjahrstagung 2020 der ÖGPath/IAP Austria; SEP 11-12,2020; Vienna, AUSTRIA. 2020. [Oral Communication]

Brcic, L Neue Erkenntnisse in der Pathobiologie des SCLC – Biomarker und NGS.
44. Jahrestagung der Österreichischen Gesellschaft für Pneumologie und der Österreichischen Gesellschaft für Thoraxchirurgie; Vienna, AUSTRIA. 2020. [Onlinepräsentation]

Brcic, L Overview of EGFR/T790M testing in 2019- Medical University of Graz.
LIVE WEBINAR: EGFR/T790M Testing; OCT 29, 2020; Zagreb, CROATIA. 2020. [Onlinepräsentation]

Brcic, L SCLC aus Sicht der Pathologie - Unterscheidung der neuroendokrinen Tumoren, zukünftige Biomarker und Wertigkeit von NGS.
44. Jahrestagung der Österreichischen Gesellschaft für Pneumologie; OCT 14, 2020; AUSTRIA. 2020. [Onlinepräsentation]

Brcic, L Herausforderungen in der (Molekular-) Pathologie des NSCLC – Was muss die Pathologie 2020 leisten und was benötigt sie dafür?
Seltene genetische Treiber im NSCLC – Möglichkeiten durch Präzisierung von Diagnose und Therapie (DFP-approbierte Veranstaltung) ; DEC 15, 2020; AUSTRIA. 2020. [Onlinepräsentation]

Brcic, L Ist Partikelinhalation wirklich so schlimm?
Grüne Jugend; JUN 15,2020; Graz. 2020. [Science to Public]

Fukuoka, J; Zaizen, Y; Ozasa, M; Soshi, M; Achcar, RD; Almutrafi, A; Augustyniak, J; Berezowska, S; Brcic, L; Cavazza, A; Fabro, A; Ishida, K; Moreira, A; Marchevsky, A; Roden, A; Schneider, F; Smith, M; Takano, A; Tanaka, T; Kondoh, Y; Bychkov, A Finding "Ground Truth" for the Diagnosis of UIP with Artificial Intelligence - Standardization of Diagnoses by 16 Expert Pathologists from 9 Countries.
LAB INVEST. 2020; 100(SUPPL 1):1773-1774.-109th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP); FEB 29-MAR 05, 2020; Los Angeles, CA. [Poster]
Web of Science

Fukuoka, J; Zaizen, Y; Ozasa, M; Soshi, M; Achcar, RD; Almutrafi, A; Augustyniak, J; Berezowska, S; Brcic, L; Cavazza, A; Fabro, A; Ishida, K; Moreira, A; Marchevsky, A; Roden, A; Schneider, F; Smith, M; Takano, A; Tanaka, T; Kondoh, Y; Bychkov, A Finding "Ground Truth" for the Diagnosis of UIP with Artificial Intelligence - Standardization of Diagnoses by 16 Expert Pathologists from 9 Countries.
MODERN PATHOL. 2020; 33(SUPPL 2):1773-1774.-109th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP); FEB 29-MAR 05, 2020; Los Angeles, CA. [Poster]
Web of Science

Gallob, F; Brcic, L; Zombori, T; Eidenhammer, S; Timens, W; Popper, HH What cells are replacing the epithelium in cystic remodeling in UIP and COPD.
EUR RESPIR J. 2020; 56: Doi: 10.1183/13993003.congress-2020.3380 [Poster]
Web of Science FullText FullText_MUG

Greimel, T; Strenger, V; Egger, M; Haber, E; Brcic, L; Konig, E; Modl, M; Pfleger, A; Eber, E Bronchial Anthracofibrosis in an Adolescent with Tuberculosis.
WIEN KLIN WOCHENSCHR. 2020; 132(19-20):597-597.-44. Jahrestagung der Österreichischen Gesellschaft für Pneumologie, 4. Jahrestagung der Österreichischen Gesellschaft für Thoraxchirurgie; OCT 14-16, 2020; Vienna, AUSTRIA (online). [Oral Communication]
Web of Science

Grossmann, T; Karbiener, M; Kirsch, A; Grill, M; Birner-Grünberger, R; Darnhofer, B; Brcic, L; Gugatschka, M In vitro bioengineering and characterization of human laryngeal mucosa constructs.
12th International Conference on Voice Physiology and Biomechanics ICVPB 2020; DEC 2-4, 2020; Grenoble, FRANCE. 2020. [Onlinepräsentation]

Husain, A; Schulte, J; Attanoos, R; Brcic, L; Butnor, K; Chirieac, L; Churg, A; Hiroshima, K; Hung, Y; Kindler, H; Krausz, T; Marchevsky, A; Nabeshima, K; Walts, A; Chapel, D Toward a Comprehensive Prognostic Model for Malignant Peritoneal Mesothelioma: An International Collaboration.
LAB INVEST. 2020; 100(SUPPL 1):1782-1784.-109th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP); FEB 29-MAR 05, 2020; Los Angeles, CA. [Poster]
Web of Science

Husain, A; Schulte, J; Attanoos, R; Brcic, L; Butnor, K; Chirieac, L; Churg, A; Hiroshima, K; Hung, Y; Kindler, H; Krausz, T; Marchevsky, A; Nabeshima, K; Walts, A; Chapel, D Toward a Comprehensive Prognostic Model for Malignant Peritoneal Mesothelioma: An International Collaboration.
MODERN PATHOL. 2020; 33(SUPPL 2):1782-1784.-109th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP); FEB 29-MAR 05, 2020; Los Angeles, CA. [Poster]
Web of Science

Leopold, J; Brcic, L; Eidenhammer, S; Timens, W; Popper, HH Degeneration of nerve fibers in chronic obstructive lung disease and usual interstitial pneumonia.
EUR RESPIR J. 2020; 56: Doi: 10.1183/13993003.congress-2020.2899 [Poster]
Web of Science FullText FullText_MUG

Skalova, A; Vanecek, T; Martinek, P; Ptakova, N; Agaimy, A; Laco, J; Brcic, L; Baneckova, M; Koshyk, O; Michal, M Novel Rearrangements in Salivary Gland Tumors Detected by Next Generation Sequencing Assay: Series of 104 Fusion Positive Cases.
LAB INVEST. 2020; 100(SUPPL 1):1228-1229.-109th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP); FEB 29-MAR 05, 2020; Los Angeles, CA. [Oral Communication]
Web of Science

Skalova, A; Vanecek, T; Martinek, P; Ptakova, N; Agaimy, A; Laco, J; Brcic, L; Baneckova, M; Koshyk, O; Michal, M Novel Rearrangements in Salivary Gland Tumors Detected by Next Generation Sequencing Assay: Series of 104 Fusion Positive Cases.
MODERN PATHOL. 2020; 33(SUPPL 2):1228-1229.-109th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP); FEB 29-MAR 05, 2020; Los Angeles, CA. [Oral Communication]
Web of Science

Smolle, E; Leko, P; Stacher-Priehse, E; Brcic, L; El-Heliebi, A; Hofmann, L; Quehenberger, F; Hrzenjak, A; Popper, H; Olschewski, H; Leithner, K Distribution and prognostic significance of gluconeogenic and glycolytic phenotypes in non-small cell lung cancer.
WIEN KLIN WOCHENSCHR. 2020; 132(19-20):621-622.-Annual Meeting of the Austrian Society of Pulmonology; OCT 14-16, 2020; virtual. [Oral Communication]
Web of Science

Smolle, E; Leko, P; Stacher-Priehse, E; Brcic, L; El-Heliebi, A; Hofmann, L; Quehenberger, F; Hrzenjak, A; Popper, H; Olschewski, H; Leithner, K Expression pattern and prognostic significance of gluconeogenesis enzymes in lung cancer.
Abstracts | IASLC 2020 World Conference on Lung Cancer | Singapore, Worldwide Virtual Event. 2020; 1211--IASLC - WCLC 2020 World Conference on Lung Cancer Singapore; JAN 28-31, 2020; Singapore (online). [Poster]
FullText

Tubin, S; Grusch, M; Popper, HH; Brcic, L; Jeremic, B SBRT-Partial Tumor Irradiation for The Treatment of Unresectable Bulky.
INT J RADIAT ONCOL. 2020; 108(3):E111-E111.-62nd Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO); OCT 25-28, 2020; ELECTR NETWORK. [Oral Communication]
Web of Science

Brcic, L Molecular pathology of lung cancer.
Archive of Oncology. 2019; 25: -SECOND REGIONAL CONGRESS OF MEDICAL ONCOLOGY; MAY 16-18, 2019; Belgrade, SERBIA. [Oral Communication]

Brcic, L Metastases to the lung.
Presentation in Centre Leon Berard; FEB 26, 2019; Lyon, FRANCE. 2019. [Oral Communication]

Brcic, L Rare tumors of mediastinum- Case 4.
31st European Congress of Pathology; SEP 7-11, 2019; Nice, FRANCE. 2019. [Oral Communication]

Brcic, L Are there any new tissue biomarkers useful for diagnosis?
Virchows Archiv. 2019; -31st European Congress of Pathology; SEP 7-11, 2019; Nice, FRANCE. [Oral Communication]

Brcic, L Pathologische Diagnostik: State of the Art und Ausblick in die nahe Zukunft.
Lung Cancer Insight; JAN 22, 2019; Graz, AUSTRIA. 2019. [Oral Communication]

Brcic, L Diagnostischer Algorithmus.
Patho-Pneumo Tumortalk; SEP 13, 2019; Vienna, AUSTRIA. 2019. [Oral Communication]

Brcic, L Utilization of IHC in Differential Diagnosis of Mesothelial Tumours vs. Metastatic Cancer.
31st Annual Congress of the International Academy of Pathology Arab Division; OCT, 23-26, 2019; Hurghada, EGYPT. 2019. [Oral Communication]

Brcic, L Mesothelioma Virtual Bank
3. Grazer Lungentag; OCT 16, 2019; Graz, AUSTRIA. 2019. [Oral Communication]

Brcic, L Mundschleimhautpathologie / Biopsie.
International Postgraduate Summer School in Dentistry; JUL 1-5, 2019; Graz, AUSTRIA. 2019. [Oral Communication]

Brcic, L The role of pathology in the era of immunotherapy.
27th Ljudevit Jurak International Symposium on Comparative Pathology with One Health Session; MAY 31-JUN 1, 2019; Zagreb, CROATIA. 2019. [Oral Communication]

Brcic, L. Lung Cancer Diagnostics (pathology).
International Lung Cancer Diagnostics Workshop; SEP 16-17, 2019; Graz, AUSTRIA. 2019. [Oral Communication]

Dandachi, N; Absenger, G; Brcic, L; Kashofer, K; Terbuch, A; Jaritz, L; Stanzer, S; Balic, M Feasibility and clinical value of serial circulating tumor DNA testing in metastatic lung adenocarcinoma patients undergoing TKI treatment
ONCOL RES TREAT. 2019; 42: 213-213. [Poster]
Web of Science

Dandachi, N; Suppan, C; Brcic, L; Tiran, V; Mueller, DH; Posch, F; Ulz, P; Heitzer, E; Balic, M Monitoring therapy response and assessing prognosis by untargeted FAST-SeqS of circulating tumor DNA in metastatic breast cancer patients
ONCOL RES TREAT. 2019; 42: 41-41. [Poster]
Web of Science

Kashofer, K; Thueringer, A; Brcic, L; Gorkiewicz, G Pulmonary amoebic abscess - resolved with application of metagenomics (universal pathogen detection).
VIRCHOWS ARCH. 2019; 475: S119-S119.-31st European Congress of Pathology; SEP 7-11, 2019; Nice, FRANCE. [Poster]
Web of Science

Kohlmaier, B; Strenger, V; Egger, M; Modl, M; Pfleger, A; Gugatschka, M; Brcic, L; Gorkiewicz, G; Eber, E Persistierender Stridor bei einem 10-jährigen Patienten mit zystischer Fibrose.
Monatsschrift Kinderheilkunde. 2019; S305--57. Jahrestagung der Österreichischen Gesellschaft für Kinder- und Jugendheilkunde (ÖGKJ); SEP 19-21, 2019; Klagenfurt, AUSTRIA. [Poster]

Opitz, I; Bille, A; Tsourti, Z; Nakaerts, K; Ampollini, L; De Perrot, M; Brcic, L; Nadal, E; Gray, S; Aerts, J; Verbeken, E; Silini, E; Zaeimi, F; Samarzija, M; Llatjos, R; Tsimpoukis, S; van der Thusen, JH; Finn, S; Marti, N; Dimopoulou, G; Monkhorst, K; Brunello, A; Kammler, R; Soltermann, A; Falcoz, P; Baas, P; Stahel, R; Mesoscape, FE; Consortia, FE Realtime Data from Europe ETOP / ESTS Database
J THORAC ONCOL. 2019; 14(10):S93-S94.-IASLC 2019 World Conference on Lung Cancer; SEP 7-10, 2019; Barcelona, SPAIN. Doi: 10.1016/j.jtho.2019.08.210 [Oral Communication]
Web of Science FullText FullText_MUG

Popper, HH; Stacher-Priehse, E; Brcic, L; Eidsenhammer, S; Gallob, F; Rampp, F; Nerlich, A Autophagy and senescence are activated mechanisms in idiopathic or autoimmunity caused usual interstitial pneumonia
EUR RESPIR J. 2019; 54: Doi: 10.1183/13993003.congress-2019.PA5379 [Poster]
Web of Science FullText FullText_MUG

Schulte, J; Attanoos, R; Brcic, L; Butnor, K; Chapel, D; Dacic, S; Fukuoka, J; Salle, FG; Godschachner, T; Hiroshima, K; Klebe, S; Krausz, T; Litzky, L; Marchevsky, A; Mueller, J; Nicholson, A; Roden, A; Santoni-Rugiu, E; Tazelaar, H; Walts, A; Weynand, B; Zhang, YZ; Husain, A Biopsy Accurately Predicts Resection Pathologic Parameters in Malignant Mesothelioma: A Multi-Institutional Analysis.
MODERN PATHOL. 2019; 32: -108th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) - Unlocking Your Ingenuity; MAR 16-21, 2019; National Harbor, MD, USA. [Poster]
Web of Science

Schulte, J; Attanoos, R; Brcic, L; Butnor, K; Chapel, D; Dacic, S; Fukuoka, J; Salle, FG; Godschachner, T; Hiroshima, K; Klebe, S; Krausz, T; Litzky, L; Marchevsky, A; Mueller, J; Nicholson, A; Roden, A; Santoni-Rugiu, E; Tazelaar, H; Walts, A; Weynand, B; Zhang, YZ; Husain, A Biopsy Accurately Predicts Resection Pathologic Parameters in Malignant Mesothelioma: A Multi-Institutional Analysis.
LAB INVEST. 2019; 99: -108th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) - Unlocking Your Ingenuity; MAR 16-21, 2019; National Harbor, MD, USA. [Poster]
Web of Science

Skalova, A; Conceicao, TS; Vanecek, T; Brcic, L; Hyrcza, M; Simpson, R; Baneckova, M; Horakova, M; Michal, M Salivary secretory carcinoma with a novel VIM-RET fusion: NGS based molecular profiling of 49 cases revealed an expanding molecular spectrum of a recently described entity.
MODERN PATHOL. 2019; 32: -108th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) - Unlocking Your Ingenuity; MAR 16-21, 2019; National Harbor, MD, USA. [Poster]
Web of Science

Skalova, A; Conceicao, TS; Vanecek, T; Brcic, L; Hyrcza, M; Simpson, R; Baneckova, M; Horakova, M; Michal, M Salivary secretory carcinoma with a novel VIM-RET fusion: NGS based molecular profiling of 49 cases revealed an expanding molecular spectrum of a recently described entity
LAB INVEST. 2019; 99: -108th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) - Unlocking Your Ingenuity; MAR 16-21, 2019; National Harbor, MD, USA. [Poster]
Web of Science

Smolle, E; Leko, P; Stacher-Priehse, E; Brcic, L; El-Heliebi, A; Hofmann, L; Quehenberger, F; Popper, H; Olschewski, H; Leithner, K Gluconeogenic and glycolytic phenotypes are inversely correlated in lung adenocarcinoma and show differential association with outcome.
Abstract Book of the Doctoral Day at the Medical University Graz 2019. 2019; -Doctoral Day; NOV 21, 2019; Graz, AUSTRIA. [Poster]

Tubin, S; Popper, H; Brcic, L Novel Partial Tumor Irradiation Improves Treatment Outcomes for Inoperable Bulky Lung Cancer Compared with Standard of Care
J THORAC ONCOL. 2019; 14(10):S915-S915.-IASLC 2019 World Conference on Lung Cancer; SEP 7-10, 2019; Barcelona, SPAIN. Doi: 10.1016/j.jtho.2019.08.1986 [Poster]
Web of Science FullText FullText_MUG

Weiland, T; Eckert A; Tomazic PV; Wolf A; Pondorfer P; Vasicek S; Graupp M; Holzmeister C; Moser U; Andrianakis A; Kangler G; Kiss P; Brcic L; Kappler M; Wickenhauser C; Haak A; Krüger M; Al-Nawas B; Blatt S; Brockmeyer N; Skaletz-Rorowski A; Potthoff A; French LE; Charnowski S; Reinholz M; Kaufmann AM; Thies S; Lambrecht HG; Seliger B; Wild DC; Thurnher D DRH1 - Evaluierung eines Blut-basierten HPV Tumormarkers.
Abstractband 63. Österreichischer HNO-Kongress 2019. 2019; -63. Österreichischer HNO Kongress 2019; Sept 11-15, 2019; Salzburg. [Oral Communication]

Weiland, T; Tomazic, PV; Wolf, A; Brcic, L; Pondorfer, P; Vasicek, S; Holzmeister, C; Graupp, M; Thurnher, D DRH1 - Evaluating a blood-based marker for HPV16-induced tumors
Abstract Band - EUROGIN 2019 - International Multidisciplinary HPV Congress. 2019; -EUROGIN 2019 - International Multidisciplinary HPV Congress; Dez 4-7, 2019; Monaco. [Poster]

Zacharias, M; Brcic, L; Kashofer, K; Gorkiewicz, G Pulmonary nocardiosis diagnosed by panbacterial (16S rRNA gene) sequencing - a series of 3 cases.
Virchows Archiv. 2019; 475: S121-S121.-31st European Congress of Pathology; SEP 7-11, 2019; Nice, FRANCE. [Poster]
Web of Science FullText

Zacharias, M; Brcic, L; Kashofer, K; Gorkiewicz, G 16S rRNA gene sequencing versus traditional microbiological culture as a tool for investigating inflammatory thoracic lesions - a case series.
Der Pathologe. 2019; 40(6):682-682.-4th Joint Annual Meeting of the Swiss and Austrian Societies of Pathology; NOV 7-9, 2019; Lucerne, SWITZERLAND. [Poster]
FullText

Zacharias, M; Brcic, L; Kashofer, K; Gorkiewicz, G Inflammatory pseudotumour of the chest - a medical conundrum solved with 16S rRNA gene sequencing.
Virchows Archiv. 2019; 475: S121-S121.-31st European Congress of Pathology; SEP 7-11, 2019; Nice, FRANCE. [Poster]
Web of Science FullText

Brcic, L Update Pathologie
Expertenmeeting Lungenkarzinom; APR 25, 2018; GRAZ. 2018. [Oral Communication]

Brcic, L Pathology of malignant pleural mesothelioma.
17th Central European Lung Cancer Conference including Best of WCLC 2018 ; NOV 30 - DEZ 02, 2018; Novi Sad, SERBIA. 2018. [Oral Communication]

Brcic, L What should pulmonologist know about lung carcinoma pathology?
7th CONGRESS OF CROATIAN PULMONOLOGISTS with international participation; OCT 11-14, 2018; Dubrovnik, CROATIA. 2018. [Oral Communication]

Brcic, L Linking acute infection to chronic lung disease
30th European Congress of Pathology; SEP 8-12, 2018; Bilbao, SPAIN. 2018. [Oral Communication]

Brcic, L Role and importance of PDL-1 testing in NSCLC: challenges for implementation.
Local expert meeting- pulmonologist and pathologist joint session; NOV 10, 2018; Sarajevo, BOSNIEN UND HERZEGOWINA. 2018. [Oral Communication]

Brcic, L Access to molecular testing in NSCLC in CEE countries: results of the CECOG field analysis.
CEE Lung Cancer Academy; NOV 16-17, 2018; Vienna, AUSTRIA. 2018. [Oral Communication]

Brcic, L Are we on the right pathway to find predictive immunotherapy biomarker(s)?
Immunotherapy in lung cancer. Regional Meeting.; DEC 14-15, 2018; Bled, SLOVENIA. 2018. [Oral Communication]

Brcic, L ALK protein analysis in lung adenocarcinoma – how do we improve it?
Local expert meeting- pulmonologist and pathologist joint session; NOV 10, 2018; Sarajevo, BOSNIEN UND HERZEGOWINA. 2018. [Oral Communication]

Brcic, L HNO- und Oralpathologie.
Pathology Future Academy: Intensivseminar Basics in Pathology 2018; NOV 30 - DEZ 01, 2018; Schloss Seggau, Leibnitz, AUSTRIA. 2018. [Oral Communication]

Brcic, L Lecture & Discussion: Metastasis to the lung
Postgraduate Course Lung & Pleural Diseases; JUN 14-20, 2018; Graz, AUSTRIA. 2018. [Oral Communication]

Brcic, L Case teaching & Lecture: Emphysema & COPD
Postgraduate Course Lung & Pleural Diseases; JUN 14-20, 2018; Graz, AUSTRIA. 2018. [Oral Communication]

Brcic, L Rare lung tumors-case presentation
Slovenian Society of Pathology and Forensic Medicine Spring Meeting 2018; MAY 26-27, 2018; Goriska Brda, SLOVENIA. 2018. [Oral Communication]

Brcic, L Pathologisch diagnostischer Algorithmus des NSCLC.
Lung cancer insight Steiermark; FEB 2, 2018; Graz, AUSTRIA. 2018. [Oral Communication]

Brcic, L Praktični aspekti molekularne patologije u terapiji karcinoma pluća. (Practical approach to molecular pathology in lung cancer therapy).
TREĆA UMOS ŠKOLA O KARCINOMU PLUĆA: MOLEKULARNO CILJANA I IMUNOLOŠKA TERAPIJA; JAN 19, 2018; Belgrade, SERBIA. 2018. [Oral Communication]
FullText

Brcic, L Mesotheliom Diagnostik.
Frühjahrstagung der Österreichischen Gesellschaft für Pathologie (ÖGPath)/Österreichische Abteilung der IAP (IAP Austria); MAR 9-10, 2018; Vienna, AUSTRIA. 2018. [Oral Communication]

Brcic, L PD-L1 kao prediktivni biomarker i izazovi u implementaciji testiranja u kliničkoj parksi. (PD-L1 as predictive biomarker and testing implementation challenges in clinical practice).
IZAZOVI U IMPLEMENTACIJI PD-L1 TESTIRANJA (CHALLENGES IN PD-L1 TESTING IMPLEMENTATION); JAN 18, 2018; Belgrade, SERBIA. 2018. [Oral Communication]

Brcic, L Šta internistički onkolog treba da zna o molekularnoj patologiji karcinoma pluća? (What should oncologist know about pathology and molecular diagnostics of lung carcinoma)
TREĆA UMOS ŠKOLA O KARCINOMU PLUĆA: MOLEKULARNO CILJANA I IMUNOLOŠKA TERAPIJA; JAN 19, 2018; Belgrade, SERBIA. 2018. [Oral Communication]
FullText

Brcic, L Case teaching & Lecture: Smoking associated lung diseases
Postgraduate Course Lung & Pleural Diseases; JUN 14-20, 2018; Graz, AUSTRIA. 2018. [Oral Communication]

Brcic, L Case teaching and Lecture: Granulomatous lung diseases
Postgraduate Course Lung & Pleural Diseases; JUN 14-20, 2018; Graz, AUSTRIA. 2018. [Oral Communication]

Brcic, L Head & Neck Slide Seminar-Case 4
5th Pannonia Congress of Pathology; MAY 16-19, 2018; Mikulov, CZECH. 2018. [Oral Communication]

Brcic, L; Cufer, T; Ryska, A; Ciuleanu, T; Zielinski, C Availability and Reimbursement of Diagnostic Testing and Novel Anti-Cancer Drugs for NSCLC in CEE: Results of a CECOG Survey
J THORAC ONCOL. . 2018; 13(10):S818-S818.-IASLC 19th World Conference on Lung Cancer; SEP 23-26, 2018; Toronto, CANADA. Doi: 10.1016/j.jtho.2018.08.1444 [Poster]
Web of Science FullText FullText_MUG

Brezinschek, HP Synoviaanalyse
Infiltrationskurs; JAN 19-20, 2018; Graz, AUSTRIA. 2018. [Keynote lecture]

Gallob, M; Brcic, L; Brcic, I; Thurnher, D; Wolf, A PD-L1 expression in oropharyngeal carcinomas and paired lymph node metastases.
Herbsttagung 2018 der ÖGPath/IAP Austria. Der Pathologe . 2018; 39(5):482-482.-Herbsttagung 2018 der ÖGPath/IAP Austria. ; SEP 27-28, 2018; Graz, AUSTRIA. [Poster]

Gantenbein, N; Bernhart, E; Anders, I; Golob-Schwarzl, N; Krassnig, S; Wodlej, C; Gogg-Kamerer, M; Lindenmann, J; Fink-Neuboeck, N; Brcic, L; Gollowitsch ,F; Stacher-Priehse ,E; Rolff , J; Hoffmann , J; Silvestri ,A; Regenbrecht ,C; Reinhard, C; Pehserl , AM; Pichler ,M; Sokolova , O; Naumann ,M; Mitterer ,V; Pertschy,B; Bergler, H; Popper, H; Sattler , W; Haybaeck, J Influence of eukaryotic translation initiation factors in non-small cell lung cancer development and progression
30th European Congress of Pathology, Pathology: Path to Precision medicine; SEP 10, 2018; Bilbao, SPAIN. 2018. [Poster]

Gungl, A; Slaven, C; Biasin, V; Marsh, LM; Odler, B; Sahu-Osen, A; Brcic, L; Ghanim, B; Klepetko, W; Graninger, W; Olschewski, A; Olschewski, H; Kwapiszewska, G Blockade of IL-1 signalling exacerbates Th2 inflammation in the Fra-2 transgenic mouse model of systemic sclerosis
WIEN KLIN WOCHENSCHR. 2018; 130(19-20):605-606. [Poster]
Web of Science

Hirsch, T; Pondorfer, P; Brcic, L; Vasicek, S; Weiland, T; Wolf, A; Graupp, M; Holzmeister, C; Moser, U; Schwab, K; Thurnher, D Prognose für Patienten mit Weichteilmetastasen bei Karzinomen im Kopf- und Halsbereich
62. Österreichischer HNO-Kongress ; OKT 10-14, 2018; Bregenz, Austria. 2018. [Oral Communication]

Moll, HP; Pranz, K; Musteanu, M; Brcic, L; Popper, H; Moldvay, J; Dome, B; Casanova, E Afatinib restrains K-RAS driven lung tumorigenesis
CANCER RES. 2018; 78(13):-Annual Meeting of the American-Association-for-Cancer-Research (AACR); APR 14-18, 2018; Chicago, IL. Doi: 10.1158/1538-7445.AM2018-809 [Poster]
Web of Science FullText FullText_MUG

Pondorfer, P; Brcic, L; Vasicek, S; Weiland, T; Wolf, A; Holzmeister, C; Moser, U; Hirsch, T; Thurnher, D; Soft tissue metastasis in head and neck carcinomas – an undefined pathological phenomenon.
http://www.echno2018.com/wp-content/uploads/2018/04/Young-Scientists-Forum.pdf. 2018; -ECHNO; APR 11-14, 2018; Rom, ITALY. [Oral Communication]
FullText

Pondorfer, P; Brcic, L; Vasicek, S; Weiland, T; Holzmeister, C; Moser, U; Thurnher, D; oft tissue metastasis or regional neck metastasis?.
2nd International Symposium on Tumor-Host Interaction in Head and Neck Cancer 3rd International Symposium on HPV Infection in Head and Neck Cancer ; JAN 25–27, 2018; Essen, Germany. 2018. [Poster]
FullText

Pondorfer, P; Vasicek, S; Weiland, T; Graupp, M; Holzmeister, C; Moser, U; Wolf, A; Schwab, K; Kangler, G; Brcic, L; Hirsch, T; Thurnher, D Krankheitsfreies und Gesamt-Überleben von Patienten mit Plattenepithelkarzinom des Oropharynx – ein Vergleich verschiedener chirurgischer Therapien in Abhängigkeit von p16
62. Österreichischer HNO-Kongress ; OKT 10-14, 2018; Bregenz, Austria. 2018. [Oral Communication]

Steinbacher, M; Pfleger, A; Karastaneva, A; Brcic, L; Lackner, H; Benesch, M; Eber, E Kaposiforme Lymphangiomatose der Lunge - Therapie mit Sirolimus.
Monatsschrift Kinderheilkunde. 2018; 166, Suppl. 3: S204--56. Jahrestagung der Österreichischen Gesellschaft für Kinder- und Jugendheilkunde (ÖGKJ); SEP 27-29, 2018; Linz, AUSTRIA. [Poster]

Stumptner, C; Brcic, I; Brcic, L Pathology and Biobanking University Workshops for Children
Der Pathologe. 2018; 39(5):488-488.-Herbsttagung der ÖGPath/IAP Austria; SEP 27-28, 2018; Graz, AUSTRIA; Graz, AUSTRIA. [Poster]

Stumptner, C; Brcic, I; Brcic, L Biobanking and Pathology University Workshops for Children
Europe Biobank Week ; SEP 4-7, 2018; Antwerp, BELGIUM. 2018. [Poster]

Van Seijen, M; Brcic, L; Navarro, A; Sansano, I; Bendek, M; Witte, B; Brcic, I; Kammler, R; Stahel, RA; Thunnissen, E Influence of delayed and prolonged fixation on the evaluation of immunohistochemical staining on pulmonary resection specimen
J THORAC ONCOL. 2018; 13(4):S11-S11.-ELCC 2018 European Lung Cancer Congress; APR 11-14, 2018; Geneva, SWITZERLAND. Doi: 10.1016/S1556-0864(18)30301-0 [Poster]
Web of Science FullText FullText_MUG

Vlacic, G; Hoda, A; Brcic, L; Jakopovic, M; Mohorcic, K; Seiwerth, S; Rajer, M; Klikovits, T; Laszlo, V; Dome, B; Klepetko, W; Berger, W; Pirker, R; Kern, I; Grusch, M Expression of FGFRs and evaluation of efficacy of different TKIs against FGFR1-4 in MPM.
14th meeting of the International Mesothelioma Interest Group (iMig 2018); MAY 2-5, 2018; Ottawa, CANADA. 2018. [Oral Communication]

Weiland, T; Wolf, A; Vasicek, S; Pondorfer, P; Holzmeister, C; Moser, U; Brcic, L; Thurnher, D Detection of serological HPV16 status in the course of therapy in patients with oropharyngeal carcinoma
3rd International Symposium on HPV Infection in Head and Neck Cancer; Jan 25-27, 2018; Essen, Deutschland. 2018. [Oral Communication]

Weiland, T; Wolf, A; Vasicek, S; Pondorfer, P; Holzmeister, C; Moser, U; Brcic, L; Thurnher, D Detection of serological HPV16-L1 status in the Course of therapy in patients with oropharyngeal carcinoma
Abstract Band 8th European Congress on Head and Neck Oncology. 2018; -8th European Congress on Head and Neck Oncology; Apr 11-14, 2018; Rome, Italy. [Poster]

Weiland T; Wolf A; Vasicek S; Pondorfer P; Holzmeister C; Moser U; Brcic L; Thurnher D Detection of serological HPV16 Status in the Course of therapy in patients with oropharyngeal carcinoma
Joint Meeting of the Czech and Austrian Head and Neck Cancer Cooperative Group with participation of Slovak HNC Cooperative Group Preparatory Committee; JUN 7-8, 2018; Znojmo, Slovakei. 2018. [Oral Communication]

Zacharias, M; Brcic, L; Eidenhammer, S; Popper, H Bulk tumour cell migration is more common than classical epithelial-mesenchymal transition in lung carcinomas.
Abstracts, 30thEuropean Congress of Pathology Virchows Archiv. 2018; 473: S113-S113.-30th European Congress of Pathology; SEP, 8-12, 2018; Bilbao, SPAIN. [Poster]
Web of Science

Brcic, L Mesotheliome: Diagnostik in Europa – Frankreich, Deutschland, Schweiz, Österreich, Slowenien u.a. was kann die Pathologie zum österreichischen Mesotheliomregister beitragen?
Herbsttagung 2017 der Österreichischen Gesellschaft für Pathologie (ÖGPath)/Österreichische Abteilung der IAP (IAP Austria) ; SEP 14-16, 2017; Velden, AUSTRIA. 2017. [Oral Communication]

Brcic, L New potential biomarkers for immunotherapy.
Immunotherapy in lung cancer, Regional meeting; DEZ 15-16, 2017; Bled, SLOVENIA. 2017. [Oral Communication]

Brcic, L Highlights of the IASLC18th World Conference on Lung Cancer.
Interne Fortbildungsveranstaltung des Instituts für Pathologie der Medizinischen Universität Graz; 13.11.2017; Graz, AUSTRIA. 2017. [Oral Communication]

Brcic, L Interstitielle Erkrankungen im Kindesalter – was ist für die Diagnose erforderlich?
GRAZER LUNGENTAG; 15.11.2017; Graz, AUSTRIA. 2017. [Oral Communication]

Brcic, L Nicht-Tumor Pathologie der Lunge.
Intensivseminar Basics in Pathology 2017 ; 16.11.2017; Seggau, AUSTRIA. 2017. [Oral Communication]

Brcic, L Tumorpathologie der Lunge und Pleura.
Intensivseminar Basics in Pathology 2017 ; 16.11.2017; Seggau, AUSTRIA. 2017. [Oral Communication]

Brcic, L What should oncologist know about pathology and molecular diagnostics of lung carcinoma.
1st regional congress of medical oncology and 1 regional congress of oncology pharmacy; MAI 4-7, 2017; Dubrovnik, CROATIA. 2017. [Oral Communication]

Brcic, L Neue Wege in der personalisierten Medizin: Was kann die Molekularpathologie für NSCLC-PatientInnen leisten?
16. Onkologischen Wintergesprächen; Jan 20-21, 2017; Linz. 2017. [Oral Communication]

Brcic, L Histologic subtyping of mesothelioma.
2017 Pulmonary Pathology Society Biennial Meeting; JUN 13-16, 2017; Chicago, IL, USA. 2017. [Oral Communication]

Brcic, L Mesothelioma – histologic subtyping and differential diagnosis
Interne Fortbildung, Institut für Pathologie, Universität Bern; AUG 24, 2017; Bern, SWITZERLAND. 2017. [Oral Communication]

Brcic, L Importance of PD-L1 testing of NSCLC patients.
With precise diagnostic to better future for patients; Roche as partner in diagnostic and therapy.; MAI 26-27, 2017; Split, CROATIA. 2017. [Oral Communication]

Brcic, L Biomarkers in immunooncology
7. Congress of Croatian Thoracic Society; APR 26-29, 2017; Zagreb, CROATIA. 2017. [Oral Communication]

Brcic, L Prädiktive Biomarker und Bedeutung des Next Generation Sequencing bei Lungenkarzinomen.
GRAZER LUNGENTAG; 15.11.2017; Graz, AUSTRIA. 2017. [Oral Communication]

Brcic, L Integration der Liquid Biopsy in den pathologischen Befundungsablauf.
Liquid Biopsy Masterclass 2017; 17.11.2017; Graz, AUSTRIA. 2017. [Oral Communication]

Brcic, L Kopf- und Hals-Pathologie.
Kopf- & Halsonkologie-Kurs Onko Basic ; 16.11.2017; Graz, AUSTRIA. 2017. [Oral Communication]

Brcic, L Highlights der World Conference on Lung Cancer 2016
Interne Fortbildungsveranstaltung des Instituts für Pathologie der Medizinischen Universität Graz; JAN 30, 2017; Graz, AUSTRIA. 2017. [Oral Communication]

Brcic, L Differential diagnosis of mesothelioma and subtyping – the pathologist´s point of view.
Malignant Pleural Mesothelioma. Advances in diagnostics, therapy & research.; NOV 10, 2017; Essen, GERMANY. 2017. [Oral Communication]

Brcic, L; Jakopovic, M; Kern, I; Mohorcic, K; Seiwerth, S; Grusch,M; Rajer, M; Buder, A; Klikovits, T; Laszlo, V; Dome, B; Hegedus, B; Klepetko, W; Kolek, V; Hoda, MA; Filipits, M; on behalf of the Central European Mesothelioma Interest Group Investigators PD-L1 protein expression is negative prognostic factor in malignant pleural mesothelioma in central Europe.
18th World Conference on Lung Cancer ; OKT 15-18, 2017; Yokohama, JAPAN. 2017. [Poster]

Brcic, L; Leistentritt, C; Thüringer, A; Gollowitsch, F; Franz, D; Gorkiewicz, G; Kashofer, K; Höfler, G Single institution experience with massive parallel sequencing of tissue and liquid biopsy samples of lung adenocarcinoma.
Central European Lung Cancer Conference 2017; DEZ 1-3, 2017; Riga, LATVIA. 2017. [Oral Communication]

Dong, YW; Zhang, H; Schelch, K; Klikovits, T; Stockhammer, P; Jakopovic, M; Samarzija, M; Brcic, L; Reid, G; Kirschner, M; Kao, S; Opitz, I; Weder, W; Frauenfelder, T; Linh, NKTD; Klepetko, W; Van Zandwijk, N; Hegedus, B; Berger, W; Dome, B; Laszlo, V; Grusch, M; Hoda, M Circulating Fibroblast Growth Factor 18 is Elevated in Malignant Pleural Mesothelioma Patients - A Multi-Institutional Study
J THORAC ONCOL. 2017; 12(1):S247-S248.-IASLC 17th World Conference on Lung Cancer; DEC 4-7, 2016; Vienna, AUSTRIA. Doi: 10.1016/j.jtho.2016.11.234 [Oral Communication]
Web of Science FullText FullText_MUG

Gantenbein, N; Bernhart, E; Anders, I; Golob-Schwarzl, N; Gogg-Kamerer, M; Lindenmann, J; Fink-Neuboeck, N; Brcic, L; Gollowitsch, F; Stacher-Priehse, E; Rolff, J; Hoffmann, J; Silverstri, A; Regenbrecht, C; Reinhard, C; Pehserl, AM; Pichler, M; Mitterer, V; Pertschy, B; Bergler, H; Popper, H; Sattler, W; Haybaeck, J.. Eukaryotic Translation Initiation Factors impact Non Small Cell Lung Cancer
European Congress of Pathology; Sep 2.-6., 2017; Amsterdam. 2017. [Poster]

Gantenbein, N; Bernhart, E; Anders, I; Golob-Schwarzl, N; Gogg-Kammerer, M; Lindenmann, J; Fink-Neuboeck, N; Brcic, L; Gollowitsch, F; Stacher-Priehse, E; Rolff, J; Hoffmann, J; Silvestri, A; Regenbrecht, C; Reinhard, C; Pehserl, AM; Pichler, M; Mitterer, V; Pertschy, B; Bergler, H; Popper, H; Sattler, W; Haybaeck, J Eukaryotic translation initiation factors impact non small cell lung cancer
VIRCHOWS ARCH. 2017; 471: S104-S104. [Poster]
Web of Science

Gantenbein, N; Bernhart, E; Anders, I; Golob-Schwarzl, N; Lindenmann, J; Fink-Neuboeck, N; Brcic, L; Gollowitsch, F; Stacher-Priehse, E; Rolff, J; Hoffmann, J; Reinhard, C; Popper, H; Sattler, W; Haybaeck, J. Eukaryotic Translation Initiation Factors trigger Non Small Cell Lung Cancer (NSCLC)
International Student Congress; May 25-27, 2017; Graz. 2017. [Oral Communication]

Gantenbein, N; Bernhart, E; Anders, I; Lindenmann, J; Fink-Neubock, N; Brcic, L; Gollowitsch, F; Stacher-Priehse, E; Rolff, J; Hoffmann, J; Reinhard, C; Popper, H; Sattler, W; Haybaeck, J Eukaryotic Translation Initiation Factors Impact Non-Small Cell Lung Cancer
J THORAC ONCOL. 2017; 12(1):S1141-S1142. Doi: 10.1016/j.jtho.2016.11.1602 [Poster]
Web of Science FullText FullText_MUG

Gantenbein,N; Bernhart,E; Anders,I; Golob-Schwarzl,N; Lindenmann,J; Fink-Neuböck,N; Brcic,L; Gollowitsch,F; Stacher-Priehse,E; Rolff,J; Hoffmann,J; Silvestri,A; Reinhard,C; Pehserl,AM; Pichler,M; Mitterer,V; Pertschy,P; Bergler,B; Popper,H; Sattler,W; Haybaeck,J Eukaryotic Translation Initiation Factors impact Non Small Cell Lung Cancer
CBmed Biomarker Conference; 13.2.2017; Graz, AUSTRIA. 2017. [Poster]

Gungl, A; Crnkovic, S; Biasin, V; Marsh, LM; Sahu-Osen, A; Stacher-Priehse, E; Brcic, L; Schneider, F; Cikes, N; Ghanim, B; Klepetko, W; Odler, B; Kovacs, G; Eferl, R; Olschewski, H; Olschewski, A; Kwapiszewska, G Fos-Related Antigen 2 (fra-2)-Driven Interleukin-1 Expression Leads To Pulmonary Remodelling Via Interleukin-6 And Tenascin C In Systemic Sclerosis
AM J RESP CRIT CARE. 2017; 195: -International Conference of the American-Thoracic-Society (ATS); MAY 19-24, 2017; Washington, USA. [Oral Communication]
Web of Science

Jakopovic, M; Brcic, L; Misic, M; Bubanovic, G; Seiwerth, F; Drpa, G; Cucevic, B; Roglic, M; Plestina, S; Kukulj, S; Smojver-Jezek, S; Seiwerth, S; Samarzija, M EGFR, KRAS and ALK Gene Alterations in Lung Cancer Patients in Croatia
J THORAC ONCOL. 2017; 12(1):S517-S517.-IASLC 17th World Conference on Lung Cancer; DEC 4-7, 2016; Vienna, AUSTRIA. Doi: 10.1016/j.jtho.2016.11.633 [Poster]
Web of Science FullText FullText_MUG

Karakitsiou, M; Pondorfer, P; Vasicek, S; Weiland, T; Graupp, M; Holzmeister, C; Moser, U; Wolf, A; Brcic, L; Knoflach, A; Thurnher, D Interdisziplinäres Patientenmanagement: Evaluation des Therapiepfades von Patienten mit Karzinomen des Oropharynx
61. Österreichischer HNO-Kongress; SEP 13-17, 2017; Vienna, Austria. 2017. [Oral Communication]

Karakitsiou, M; Pondorfer, P; Vasicek, S; Weiland, T; Wolf, A; Graupp, M;, Thurnher, D; Efficacy and Feasibility of Multidisciplinary Management of Patients with Oropharyngeal Cancer
HN-CR-11. 2017; -IFOS Paris; JUN 24-28, 2017; Paris, France. [Poster]
FullText

Karakotsiou, M; Pondorfer, P; Vasicek, S; Weiland, T; Graupp, M;, Holzmeister, C; Moser, U; Wolf, A; Brcic, L; Knoflach, A; Thurnher, D; Quality of Surgical Treatment of Oropharyngeal Squamous Cell Carcinoma
4th European ENT Meeting CEORL HNS ; OCT 8-11, 2017; Barcelona, SPAIN. 2017. [Poster]

Knoflach, A; Pondorfer, P; Vasicek, S; Karakitsiou, M; Graupp, M; Weiland, T; Wolf, A; Holzmeister, C; Moser, U; Brcic, L; Thurnher, D Evaluation von Prä-therapeutisches Plasma Fibrinogen und C-reaktives Protein als Prognosefaktoren in Patienten mit oralen und oropharyngealen Plattenepithelkarzinomen
61. Österreichischer HNO-Kongress; SEP 13-17, 2017; Vienna, Austria. 2017. [Oral Communication]

Knoflach, A; Pondorfer, P; Vasicek, S; Karakitsiou, M; Graupp, M; Weiland, T; Wolf, A; Holzmeister, C; Moser, U; Brcic, L; Thurnher, D; Oral and oropharyngeal squamous cell carcinoma: Evaluation of pre-therapeutic Plasma Fibrinogen und C-reactive Protein as prognostic factors
4th European ENT Meeting CEORL HNS; OCT 8-11, 2017; Barcelona, SPAIN. 2017. [Oral Communication]

Krause, R; Schilcher, G; Valentin, T; Prettenthaler, H; Hackl, G; Brcic, L; Zollner-Schwetz, I; Eller, P Candica albicans induced failure of extracorporeal membrane oxygenation
MYCOSES. 2017; 60: 158-158. [Poster]
Web of Science

Leistentritt, C; Gollowitsch, F; Franz, D; Stacher-Priehse, E; Gorkiewicz, G; Kashofer, K; Brcic L Importance of massive parallel sequencing of lung adenocarcinoma in the era of precision medicine.
Der Pathologe. 2017; 38(5):-Herbsttagung 2017 der Österreichischen Gesellschaft für Pathologie (ÖGPath)/Österreichische Abteilung der IAP (IAP Austria); SEP 14-16, 2017; Velden, AUSTRIA. [Poster]

Lindenmann, J; Fink-Neuböck, N; Fediuk, M; Gschwandtner, E; Strießnig, A; Pichler, M; Bricic, L; Maier, A; Anegg, U; Smolle-Jüttner, FM The Glasgow Prognostic Score as additional independent prognostic parameter for patients with malignant pleural mesothelioma.
European Surgery, Supplement 1 Abstracts 58th Annual Meeting of the Austrian Society of Surgery. 2017; 49(1):53-53.-58. Österreichischer Chirurgenkongress; JUN 28-30, 2017; Vienna, AUSTRIA. [Oral Communication]

Lindenmann, J; Fink-Neubock, N; Porubsky, C; Fediuk, M; Gschwandtner, E; Striessnig, A; Pichler, M; Brcic, L; Maier, A; Anegg, U; Smolle-Juttner, FM The clinical impact of the Glasgow Prognostic Score as additional independent prognostic parameter for patients with malignant pleural mesothelioma
WIEN KLIN WOCHENSCHR. 2017; 129(19-20):774-774.-41. Jahrestagung der Österreichischen Gesellschaft für Pneumologie 1. Jahrestagung der Österreichischen Gesellschaft für Thoraxchirurgie; OCT 5-7, 2017; Innsbruck, AUSTRIA. [Poster]
Web of Science

Pondorfer, P; Karakitsiou, M; Vasicek, S; Weiland, T; Graupp, M; Holzmeister, C; Moser, U; Wolf, A; Brcic, L; Knoflach, A; Thurnher, D Quality of Surgical and Non-Surgical Treatment of Oropharyngeal Squamous Cell Cancer
61. Österreichischer HNO-Kongress; SEP 13-17, 2017; Vienna, Austria. 2017. [Oral Communication]

Pondorfer, P; Knoflach, A; Vasicek, S; Karakitsiou, M; Graupp, M; Weiland, T; Wolf, A; Holzmeister, C; Moser, U; Brcic, L; Thurnher, D Evaluation von Gamma-GT und ASAT als geschlechtsspezifische Prognosefaktoren in Patienten mit oralen und oropharyngealen Plattenepithelkarzinomen
61. Österreichischer HNO-Kongress; SEP 13-17, 2017; Vienna, Austria. 2017. [Oral Communication]

Pondorfer, P; Knoflach, A; Vasicek, S; Karakitsiou, M; Graupp, M; Weiland, T; Wolf, A; Holzmeister, C; Moser, U; Brcic, L; Thurnher, D; Evaluation of Gamma-GT and ASAT as gender-specific prognostic factors in patients with oral and oropharyngeal squamous cell carcinoma
4th European ENT Meeting CEORL HNS ; OCT 8-11, 2017; Barcelona, SPAIN. 2017. [Oral Communication]

Rosen, LE; Ananthanarayanan, V; Gallan, A; Tjota, MY; Attanoos, R; Alchami, FS; Brcic, L; Butnor, K; Hiroshima, K; Klampatsa, A; Litzky, L; Marchevsky, AM; Medeiros, F; Montero-Fernandez, MA; Moore, DA; Nabeshima, K; Pavlisko, EN; Sharma, A; Sheaf, M; Walls, AE; Galateau, F; Le Stang, N; Krausz, T; Husain, AN Nuclear Grade, Necrosis and Solid Growth Pattern Predict Survival in Epithelioid Malignant Mesothelioma: An International, Multi Institutional Study
LAB INVEST. 2017; 97: 492A-492A.-106th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP); MAR 04-10, 2017; San Antonio, TX. [Oral Communication]
Web of Science

Rosen, LE; Ananthanarayanan, V; Gallan, A; Tjota, MY; Attanoos, R; Alchami, FS; Brcic, L; Butnor, K; Hiroshima, K; Klampatsa, A; Litzky, L; Marchevsky, AM; Medeiros, F; Montero-Fernandez, MA; Moore, DA; Nabeshima, K; Pavlisko, EN; Sharma, A; Sheaff, M; Walts, AE; Galateau, F; Le Stang, N; Krausz, T; Husain, AN Nuclear Grade, Necrosis and Solid Growth Pattern Predict Survival in Epithelioid Malignant Mesothelioma: An International, Multi Institutional Study
MODERN PATHOL. 2017; 30: 492A-492A.-106th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP); MAR 04-10, 2017; San Antonio, TX. [Oral Communication]
Web of Science

Seiwerth, F; Bitar, L; Markelic, I; Dzubur, F; Brcic, L; Seiwerth, S; Misic, M; Roglic, M; Plestina, S; Cucevic, B; Kukulj, S; Smojver-Jezek, S; Samarzija, M; Jakopovic, M Second Line Treatment of EGFR Positive Lung Adenocarcinoma - Our Experience
J THORAC ONCOL. 2017; 12(1):S1262-S1262.-IASLC 17th World Conference on Lung Cancer; DEC 4-7, 2016; Vienna, AUSTRIA. Doi: 10.1016/j.jtho.2016.11.1782 [Poster]
Web of Science FullText FullText_MUG

Tiran, V; Lindenmann, J; Stanzer, S; Brcic, L; Heitzer, E; Ghaffari-Tabrizi, N; Fink-Neuböck, N; Popper, H; Dandachi, N; Balic, M Patient-derived Lung Adenocarcinoma Cells challenge the association of Cancer Stem Cells with Epithelial to Mesenchymal Transition.
OeGHO Frühjahrstagung; APR 6-8, 2017; Bregenz, AUSTRIA. 2017. [Poster]

Weiland, T; Wolf, A; Vasicek, S; Pondorfer, P; Holzmeister, C; Moser, U; Brcic, L; Thurnher, D Bestimmung des serologischen HPV16 Status im Verlauf der Therapie bei Patienten mit Oropharynxkarzinomen
61. Österreichischer HNO-Kongress; SEP 13-17, 2017; Vienna, Austria. 2017. [Oral Communication]

Zaric, B; Brcic, L; Buder, A; Tomuta, C; Brandstetter, A; Buresch, J; Traint, S; Stojsic, V; Kovacevic, T; Perin, B; Pirker, R; Filipits, M PD-1 Protein Expression Predicts Survival in Resected Adenocarcinomas of the Lung
J THORAC ONCOL. 2017; 12(1):S981-S981.-IASLC 17th World Conference on Lung Cancer; DEC 4-7, 2016; Vienna, AUSTRIA . Doi: 10.1016/j.jtho.2016.11.1357 [Poster]
Web of Science FullText FullText_MUG

Brcic, L Evening Specialty Conference-Pulmonary pathology "Finally Learned Something New"
USCAP Annual Meeting 2016; MAR 12-18, 2016; Seattle, WA, USA. 2016. [Oral Communication]

Brcic, L Immunoprofiling of non-small cell lung carcinoma-beyond PD-L1
Immunotherapy in Lung Cancer-Regional Meeting; DEZ 16-16, 2016; Bled, SLOVENIA. 2016. [Oral Communication]

Brcic, L Evaluation of immune tolerance mechanisms in pulmonary squamous cell and adenocarcinomas - how to interfere beyond PDL1 blockade.
13. Pneumologie Update 2016; JUN 9-11, 2016; Innsbruck, AUSTRIA. 2016. [Oral Communication]

Brcic, L Update in lung carcinoma diagnostics.
9. Croatian Oncology Congress; APR, 7-10, 2016; Porec, CROATIA. 2016. [Oral Communication]

Brcic, L; Heidinger, M; Zenko Sever, A; Fediuk, M; Jakopovic, M; Seiwerth, S; Smolle-Jüttner, FM; Popper, H Is better prognostic stratification of lung carcinoid tumours possible?
Abstracts of the XXXI International Congress of the International Academy of Pathology and the 28th Congress of the European Society of Pathology . 2016; 469(Sup 1 ):S130-S131.-XXXI International Congress of the International Academy of Pathology and the 28th Congress of the European Society of Pathology ; SEP 25-29, 2016; Cologne, GERMANY. [Poster]
Web of Science

Brcic, L; Höfler, G Oropharyngeal Karzinom in der HPV-Ära.
Symposium und Antrittsvorlesung von Univ.-Prof. Dr. Dietmar Thurnher zum Thema „Kopf- & Halsonkologie“; NOV 18, 2016; Graz, AUSTRIA. 2016. [Oral Communication]

Brcic, L; Popper, H Relation of EGFR and KRAS mutation status with phosphorylation of EGFR in lung adenocarcinomas.
Abstracts of the XXXI International Congress of the International Academy of Pathology and the 28th Congress of the European Society of Pathology . 2016; 469(Sup 1):S327-S327.-XXXI International Congress of the International Academy of Pathology and the 28th Congress of the European Society of Pathology ; SEP 25-29, 2016; Cologne, GERMANY. [Poster]
Web of Science

Dong, YW; Klikovits, T; Stockhammer, P; Brcic, L; Jakopovic, M; Reid, G; Berger, W; Laszlo, V; Dome, B; Klepetko, W; Grusch, M; Hoda, MA Elucidating the biomarker potential of circulating fibroblast growth factor 18 in malignant pleural mesothelioma - a multi-institutional study
WIEN KLIN WOCHENSCHR. 2016; 128(19-20):764-764.-40. Jahrestagung der Österreichischen Gesellschaft für Pneumologie; OCT 6-8, 2016; Vienna, AUSTRIA. [Poster]
Web of Science

Gantenbein, N; Bernhart, E; Anders, I; Lindenmann, J; Fink-Neuboeck, N; Brcic, L; Gollowitsch, F; Stacher-Priehse, E; Rolff, J; Hoffmann, J; Reinhard, C; Popper, H; Sattler, W; Haybaeck, J Eukaryotic translation initiation factors impact non small cell lung cancer.
Journal of Thoracic Oncology. 2016; 12: S599-S599.-17th World Conference on Lung cancer; DEC, 4-7, 2016; Vienna, AUSTRIA. [Poster]

Gantenbein, N;Bernhart, E; Anders, I; Lindenmann, J; Fink-Neuboeck, N; Brcic, L; Gollowitsch, F; Stacher-Priehse, E; Rolff, J; Hoffmann, J;Reinhard,C; Popper, H; Sattler, W; Haybaeck, J Eukaryotic Translation Initiation Factors impact Non Small Cell Lung Cancer
Doctoral Day; Dez 14, 2016; Graz, AUSTRIA. 2016. [Oral Communication]

Gungl, A; Crnkovic, S; Biasin, V; Marsh, L; Sahu-Osen, A; Stacher-Priehse, E; Brcic, L; Schneider, F; Cikes, N; Ghanim, B; Klepetko, W; Odler, B; Kovacs, G; Eferl, R; Olschewski, H; Olschewski, A; Kwapiszewska, G Fra-2 induces IL-1/IL-6-driven parenchymal and vascular remodelling in systemic sclerosis
WIEN KLIN WOCHENSCHR. 2016; 128(19-20):762-763. [Oral Communication]
Web of Science

Jakopovic, M; Brcic, L; Misic, M; Bubanovic, G; Seiwerth, F; Drpa, G; Cucevic, B; Roglic, M; Plestina, S; Kukulj, S; Smojver-Jezek, S; Seiwerth, S; Samarzija, M EGFR, KRAS and ALK Gene Alterations in Lung Cancer Patients in Croatia.
Journal of Thoracic Oncology. 2016; 2016(12):-17th World Conference on Lung Cancer; DEC, 4-7, 2016; Vienna, AUSTRIA. [Poster]

Kashofer, K; Brcic, L; Thueringer, A; Aigelsreiter, A; Popper, H; Hoefler, G Liquid biopsies in lung and skin cancer-a comparison of digital PCR and NGS methodologies
VIRCHOWS ARCH. 2016; 469: S42-S42. [Oral Communication]
Web of Science

Seiwerth, F; Bitar, L; Markelić, I; Dzubur, F; Brcic, L; Seiwerth, S; Misic, M; Roglić, M; Plestina, S; Čučević, B; Kukulj, S; Smojver-Jezek, S; Samarzija, M; Jakopovic, M Second Line Treatment of EGFR Positive Lung Adenocarcinoma - Our Experience.
Journal of Thoracic Oncology. 2016; 2016(12):-17th World Conference on Lung cancer; DEC, 4-7, 2016; Vienna, AUSTRIA. [Poster]

Valentin, T; Eisner, F; Schilcher, G; Hackl, G; Prettenthaler, H; Brcic, L; Krause, R; Eller, P Candica albicans induced Failure of Extracorporeal Membrane Oxygenation
http://www.oeginfekt.at/download/10-oeik_programm_9.pdf. 2016; -10. Österreichischer Infektionskongress; APR 27-30, 2016; Saalfelden am Steinernen Meer, Austria. [Poster]

Yawen Dong, Y; Zhang, H; Schelch, K; Klikovits, T; Stockhammer, P; Jakopovic, M; Samarzija, M; Brcic, L; Reid, G; Kirschner, M; Kao, S; Opitz, I; Weder, W; Frauenfelder, T; Nguyen-Kim, TDL; Klepetko, W; van Zandwijk, N; Hegedus, B; Berger, W; Dome, B; Laszlo, V; Grusch, M; Hoda, M Circulating fibroblast growth factor 18 is elevated in malignant pleural mesothelioma patients - A multi-institutional study.
Journal of Thoracic Oncology. 2016; 12(S1):S127-S128.-17th World Conference on Ling Cancer; DEC, 4-7, 2016; Vienna, AUSTRIA. [Oral Communication]

Zaric, B; Brcic, L;Buder, A; Tomuta, C; Brandstetter, A; Buresch, J; Traint, S; Stojsic, V; Kovacevic, T; Perin, B; Pirker, R; Filipits, M PD-1 protein expression predicts survival in resected adenocarcinomas of the lung.
Journal of Thoracic Oncology. 2016; 12(S1):S514-S515.-17th World Conference on Lung Cancer; DEC, 4-7, 2016; Vienna, AUSTRIA. [Poster]

Brcic, L News in pathohistological diagnosis (of lung cancer)
8th Croatian Oncological Congress; APR 09-12, 2015; Porec, CROATIA. 2015. [Oral Communication]

Brcic, L The role of pathology in the era of targeted therapies.
Biomarker testing in BiH: Evolution and Challenges; MAI 9, 2015; Konjic, Bosnia and Herzegovina. 2015. [Oral Communication]

Brcic, L Look-alikes and mimics: slide seminar.
30th Adriatic Society of Pathology International Meeting; JUN 27-28, 2015; Rovinj, CROATIA. 2015. [Oral Communication]

Brcic, L The role of pathology in the era of targeted therapies
Non-small cell lung cancer-expert forum; MAI 07, 2015; Sarajevo, Bosnia and Herzegovina. 2015. [Oral Communication]

Brcic, L Automated approach in detecting HER2 status- result optimization.
Biomarker testing in BiH: Evolution and Challenges; MAI 9, 2015; Konjic, Bosnia and Herzegovina. 2015. [Oral Communication]

Brcic, L; Gygar, E; Popper, H The impact of the epidermal growth factor receptor phosphorylation on downstream signaling in pulmonary adenocarcinomas.
VIRCHOWS ARCH. 2015; 467: S41-S41.-27th European Congress of Pathology; SEP 5-9, 2015; Belgrad, SERBIA. [Oral Communication]
Web of Science

Brcic, L; Popper, H When is it an immunologic lung disease?
VIRCHOWS ARCH. 2015; 467: S256-S257.-27th European Congress of Pathology; SEP 5-9, 2015; Belgrade, SERBIA. [Poster]
Web of Science

Brcic, L; Seiwerth, S; Popper, H Salivary gland-type tumours of the lung: a two centre experience.
15th Central European Lung Cancer Conference including Best of WCLC 2015; NOV 28 – 30, 2015; Prague, Czech Republik. 2015. [Poster]

Gantenbein, N; Anders, I; Lindenmann, J; Fink-Neuböck, N Raicht,A; Benesch, M; Brcic, L; Gollowitsch, F; Stacher-Priehse, E; Rolff, J; Hoffmann, J;Reinhard,C; Popper, H; Haybaeck, J, Eukaryotic Translation Initiation Factors impact Non Small Cell Lung Cancer
Doctoral Day; Dez 11, 2015; Graz, AUSTRIA. 2015. [Oral Communication]

Jakopovic, M; Brcic, L; Misic, M; Seiwerth, F; Drpa, G; Cucevic, B; Plestina, S; Kukulj, S; Roglic, M; Smojver-Jezek, S; Chalfe, N; Seiwerth, S; Janevski, Z; Samarzija, M Non-small cell lung cancer mutation analysis in purely caucasian Croatian population.
Journal of Thoracic Oncology, 2015:10 (9, Suppl 2). 2015; 10(9):S708-S708.-16th World Conference on Lung Cancer; SEP 6 - 9, 2015 ; Denver, USA. [Poster]
Web of Science

Jakopovic, M; Cucevic, B; Plestina, S; Kukulj, S; Roglic, M; Smojver-Jezek, S; Chalfe, N; Korsic, M; Redzepi, G; Brcic, L; Popovic, F; Badovinac, S; Samarzija, M Efficacy and safety of erlotinib in squamous cell lung cancer
Journal of Thoracic Oncology, 2015:10 (9, Suppl 2). 2015; 10(9):S423-S424.-16th World Conference on Lung Cancer; SEP 6 - 9, 2015 ; Denver, USA. [Poster]
Web of Science

Klikovits, T; Stockhammer, P; Dong, Y; Jakopovic, M; Brcic, L; Dome, B; Hegedus, B; Samarzija, M; Klepetko, W; Hoda, MA PRETREATMENT SERUM ALBUMIN LEVEL IS AN INDEPENDENT PROGNOSTIC BIOMARKER IN MALIGNANT PLEURAL MESOTHELIOMA.
European Lung Cancer Conference (ELCC), Geneva, Switzerland, 15-18 April 2015; Annals of Oncology 2015; 26 (Suppl 1) : i1 - i61. 2015; 26(Supp 1):i48-i50.-European Lung Cancer Conference (ELCC); APR 15 - 18, 2015; Geneva, SWITZERLAND. [Poster]

Riccioni, O; Vrasidas, C; Brcic, L; Armenski, G; Antovski, Lj; Seiwerth, S; Smeets, A; van Krieken, JHJM; Lazaris, AC HIPON Project: Acquiring Medical Experience through an E-learning Platform. A New Perspective in Pathology Education.
Conference proceedings. New perspectives in science education. 4th Edition.. 2015; -International Conference New Perspectives in Science Education. 4th Edition.; MAR 20-21, 2015; Florence, ITALY. (ISBN: 978-88-6292-600-3 ) [Oral Communication]

Brcic, L Update of pathohistological diagnosis of lung carcinoma.
7th Croatian Oncology Congress; APR 10-13, 2014; Rovinj, CROATIA. 2014. [Oral Communication]

Brcic, L Standard in pathohistological diagnostics of lung carcinoma
6. Croatian pulmonology congress with international participation; OKT 8-11, 2014; Dubrovnik, CROATIA. 2014. [Oral Communication]

Brcic, L; Jakopovic, M Case presentations (Lung carcinoma and TKI therapy)
Molecular diagnostics and targeted therapy in NSCLC, precongress symposium to 3rd Pannonia Congress of Pathology; MAI 14, 2014; Bled, SLOVENIA. 2014. [Oral Communication]

Juricic, M; Alilovic, M; Koprivanac, A; Pelicaric D; Smojver-Jezek, S; Brcic, L; Peros, T Cardiovascular drug-induced interstitial lung disease; case presentation
Fibrosing interstitial lung diseases of idiopathic and exogenous origin. Phenotype approach.; JUN 19-21, 2014; Prague, CZECH REPUBLIC. 2014. [Poster]

Lakiotaki, E; Vrasidas, C; Armenski, G; Brcic, L; Brcic, I;, Smeets, A; Thomopoulou, G-E; Seiwerth, S; van Krieken, H; Lazaris, AC Acquiring diagnostic experience in renal neoplastic pathology through HIPON web course
ESP Abstracts, Virchows Arch (2014) . 2014; 465: 286-286.-26th European Congress of Pathology; AUG 30-SEP 03, 2014; London, UK. [Poster]

Brcic, L Pathohistological manifestations of drug side effects on lung.
46th symposium m of Croatian pulmonologist; SEP 26-29, 2013; Mali Losinj, CROATIA. 2013. [Oral Communication]

Brcic, L, Bogovic, M; Misic, M; Seiwerth, S Cell-death factors expression in neuroblastoma.
VIRCHOWS ARCH. ESP Abstracts 2013. 2013; 463(2):188-188.-25th European Congress of Pathology; AUG 31 - SEP 4, 2013; Lisbon, PORTUGAL. [Poster]

Brcic, L; Lazaris, AC; Seiwerth, S; van Krieken, H; Agrogiannis, G; Smeets, A; Themistokleous, S; Armenski, G; Gushev, M E-modules on histopathology: A valuable online tool for students, researchers and professionals: The HIPON project.
VIRCHOWS ARCH. ESP Abstracts 2013. 2013; 463(2):227-227.-25th European Congress of Pathology; AUG 31 - SEP 4, 2013; Lisbon, PORTUGAL. [Poster]

Brcic, L Update of lung carcinoma classifications in resection specimens.
Toraks-Croatian Thoracic Society Congress; SEP 20-23 2012; Zagreb, CROATIA. 2012. [Oral Communication]

Seiwerth, S; Brcic, L; Sepac, A; Zanko, A. Expression of CXCR4 and CXCL12 in pulmonary carcinoids.
VIRCHOWS ARCH. ESP Abstracts 2012. 2012; 461: S54-S54.-24th European Congress of Pathology; SEP 8-12, 2012; Prague, Czech Republik. [Poster]

Sepac, A; Klaric, V; Zenko, A; Brcic, L; Znaor, A; Slobodnjak, Z; Smojver Jezek, S; Seiwerth, S Comparison of survival of patients with different histological subtypes of epithelioid pleural mesothelioma.
VIRCHOWS ARCH. ESP Abstracts 2012. 2012; 461: S56-S56.-24th European Congress of Pathology; SEP 08-12, 2012; Prague, Czech Republik. [Poster]

Brcic, L Pathology of lung neuroendocrine tumours.
Toraks-Croatian Thoracic Society Congress; SEP 8-11, 2011; Zagreb, CROATIA. 2011. [Oral Communication]

Brcic, L Sarcomatoid tumours of the lung.
1st Macedonian Congress of Pathology; OCT 12-16, 2011; Ohrid, FYROM. 2011. [Oral Communication]

Brcic, I; Brcic, L; Ilic, I Dermatofibroma, a neoplastic or an inflammatory lesion?
Pannonia Congress of Pathology; MAR 3-6, 2010; Graz, AUSTRIA. 2010. [Poster]

Brcic, L Pathohistological analysis of lung biopsies in collagen-vascular diseases.
5th Congress of Croatian Pulmonologists; OCT 7-10, 2010; Dubrovnik, CROATIA. 2010. [Oral Communication]

Barisic, I; Radic, B; Klicek, R; Sever, M; Ilic, S; Bilic, V; Berkopic, L; Dobric, I; Petrovic, I; Filipovic, M; Brcic, L; Brcic, I; Kolenc, D; Lovric-Bencic, M; Seiwerth, S; Sikiric, P Prolonged severe hypercalcemia induces an acute pancreatitis in rats, and shortening of QT interval and prolonation of PQ interval. The effect of the therapy with stable gastric pentadecapeptide BPC 157 (PL14736).
Journal of Physiology and Pharmacology. Book of Abstracts. . 2009; 60(Supp 2):8-8.-13th International Conference on Gastrointestinal Research 13th International Conference on Ulcer Research; SEP 10-16, 2009; Split, CROATIA. [Oral Communication]

Brcic, L; Brcic, I; Seiwerth, S; Sikiric, P The angiogenic BPC 157 potential is closely related to fulfilling healing process.
Journal of Physiology and Pharmacology. Book of abstracts.. 2009; 60(Supp 2):14-14.-13th International Conference on Gastrointestinal Research 13th International Conference on Ulcer Research; SEP 10-16, 2009; Split, CROATIA. [Oral Communication]

Coric, M; Brcic, I; Brcic, L; Dotlic, S; Kuzmanic, D Fibronectin glomerulopathy in a 34-year old male: case report.
ESP Abstracts. Virchow Arch. 2009; 455(S1):404-404.-22nd European Congress of Pathology; SEP 4-9, 2009; Florence, ITALIEN. [Poster]

Coric, M; Grabarevic, Z; Stroser, M; Andrisic, L; Waeg, G; Seiwerth, S; Hrstic, I; Brcic, L; Zarkovic, N 4-hydroxynonenal in human and animal chronic liver diseases.
20th Ljudevit Jurak international symposium on comparative pathology; JUN 5-6, 2009; Zagreb, CROATIA. 2009. [Poster]

Hrelec, M; Kliciek, R; Brcic, L; Brcic, I, Seiwerth, S; Sikiric, P Stable gastric pentadecapeptide BPC 157 in the aortic termino-terminal anastomosis and counteraction of the formation of the blood cloth in rats.
Journal of Physiology and Pharmacology. Book of Abstracts.. 2009; 60(Supp 2):38-38.-13th International Conference on Gastrointestinal Research 13th International Conference on Ulcer Research ; SEP 10-16, 2009; Split, CROATIA. [Oral Communication]

Mihovil, I; Radic, B; Brcic, L; Brcic, I; Vukoja, I; Ilic, S; Boban Blagaic, A; Seiwerth, S; Sikiric, P Beneficial effect of pentadecapeptide BPC 157 on denervated muscle in rats.
Journal of Physiology and Pharmacology. Book of Abstracts.. 2009; 60(Supp 2):56-56.-13th International Conference on Gastrointestinal Research 13th International Conference on Ulcer Research; SEP 10-16, 2009; Split, CROATIA. [Oral Communication]

Brcic, L; Cacic, M; Coric, M; Jelasic, D; Knezevic, N Placental site trophoblastic tumor and teratoma in a single tumor of the testis.
Histopathology. XXVIIth International congress of the International Academy of Pathology . 2008; 53(Supp 1):270-270.-XXVIIth International congress of the International Academy of Pathology ; OKT 12-17, 2008; Athens, GREECE. [Poster]

Kolenc, D; Brcic, L; Krizanac, S Desmoplastic small round cell tumor. A case report.
4th Croatian Congress of Pathology and Forensic Medicine with international participation; SEP 25-28, 2008; Osijek, CROATIA. 2008. [Poster]

Bonevski, A; Anzulovic, D; Meljanac, K; Brcic, L; Batelja, L; Brcic, I; Seiwerth, S Ewing sarcoma, a retrospective study.
ECP Abstracts, Virchows Arch. . 2007; 451(2):575-575.-21th European Congress of Pathology; SEP 8-13, 2007; Instanbul, TURKEY. [Poster]

Brcic, L; Anzulovic, D; Ilic, I; Loncaric, V; Kosuta, I; Stepan Giljevic , J; Orlic, D; Seiwerth, S Osteosarcoma study
22nd International Meeting of the Adriatic Society of Pathology; JUN 22-24, 2007; Grottammare, ITALY. 2007. [Oral Communication]

Loncaric, V; Batelja Vuletic, L; Crcic, L, Anzulovic, D; Brcic, I; Alilovic, M, Krizanac, S; Seiwerth, S Mesothelioma study
Adriatic Society of Pathology; JUN 22-24, 2007; Grottammare, ITALIEN. 2007. [Oral Communication]

Brcic, L; Batelja Vuletic, L; Stepan, J; Bonevski, A; Jakovljevic, G; Seiwerth, S Mast cell sarcoma of tibia.
VIRCHOW ARCH. 2ND INTER-CONGRESS OF THE EUROPEAN SOCIETY OF PATHOLOGY. 2006; 448(5):673-673.-2ND INTER-CONGRESS OF THE EUROPEAN SOCIETY OF PATHOLOGY; MAI 24-27, 2006; Ioannina, GREECE. [Poster]

Brcic, L; Loncaric, V; Alilovic, M; Batelja Vuletic, L; Sitic, S; Seiwerth, S Review of 50 patients with pleural mesothelioma.
21st International Meeting of Adriatic Society of Pathology; JUN 24-25, 2006; Trieste, ITALY. 2006. [Oral Communication]

↑ Top of page / Navigation